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ABSTRACT 
Background 
 Newfoundland and Labrador (NL) has the highest incidence and mortality rates of 
colorectal cancer (CRC) in North America. In March 2010, funding was announced for a fecal 
occult blood test (FOBT) screening program for those aged 50 – 74 years and at average risk for 
CRC. The main goal of this program is to reduce mortality from CRC through the detection of 
pre-cancerous polyps or early-stage cancer.   Research was undertaken prior to program 
implementation to survey the average risk population regarding their intention to participate in 
screening and to ascertain family physicians’ knowledge of screening guidelines, current 
screening practices and level of support for an organized screening program.  
Methods 
 Average risk individuals living in three different areas of the province were surveyed (n = 
959): a rural area with a familial cluster of high genetic risk CRC, and a rural and an urban area 
without familial clusters of high genetic risk CRC. It was hypothesized that those living in the 
area with a presence of high genetic risk CRC would be most likely to report positive intention to 
participate in screening. It was further hypothesized that between the two areas without any 
familial clustering of CRC, urban respondents would be more likely to report a positive intention 
to screen.  
The intent of the family physician survey (n = 274) was to enhance understanding of 
FOBT screening practices and level of physician support for an organized screening program. It 
was posited that the majority of physicians would be supportive of an organized FOBT screening 
program but would not necessarily be screening their average risk patients according to 
recommended guidelines.  
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Results 
 No significant association was found between intention to screen and a) presence of a 
familial cluster of high genetic risk CRC (p = 0.17), or b) residing in a rural versus urban region 
(p = 0.30). In multivariate analysis, prior awareness of FOBT [OR = 1.92, 95% CI 1.32 – 2.77, p 
= 0.001] and prior use of FOBT [OR = 1.87, 95% CI 1.18 – 2.97, p = 0.008] were significant 
predictors of positive screening intention.  
 Almost all family physicians indicated support for an organized screening program (n = 
256, 94.8%). Despite this, colonoscopy was the most commonly recommended procedure for 
screening average risk patients. Most physicians were compliant with the guideline- 
recommended age to start screening, (n = 228, 83.5%), but fewer were compliant with the 
recommended age for stopping (n = 66, 25%).  
Conclusions 
 Presence of a familial cluster of high genetic risk CRC did not appear to positively 
impact the screening intention of average risk individuals. Based on previous research, a higher 
than expected level of positive intention to screen was reported across all regions that were 
sampled. Similarly, it was unanticipated that almost all family physicians would be supportive of 
an organized screening program. Follow-up research, post-implementation of the screening 
program, will provide an opportunity to determine whether reported intention and support 
translate into high rates of participation and physician referral for screening.   
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Chapter one 
 Introduction 
1.1 Context - The Provincial Colorectal Cancer Screening Program 
 In March 2010, funding was announced for the Newfoundland and Labrador (NL) 
Colorectal Cancer Screening Program. The main goal of this program is to reduce 
mortality in the province due to colorectal cancer (CRC), through the detection of pre-
cancerous polyps or early-stage CRC.  The program will be phased in over a three-year 
period starting with an initial dissemination of 2000 home fecal immunochemical test kits 
in the first year. The second year will see dissemination of kits increase to 10,000 home 
kits, with full provincial implementation planned for the third year. 
This home-based screening program is intended for the population at average risk 
of developing CRC. The risk of developing CRC is broadly categorized into two groups, 
the average risk population and the high risk population. Approximately 80% of people 
with CRC appear to have sporadic disease with no evidence of inheriting the disorder 
(average risk), and the remaining 20% appear to have familial or hereditary risk1 (high 
risk).  A proportion of the high risk cases are related to two main genetic predispositions, 
namely familial adenomatous polyposis / attenuated familial adenomatous polyposis 
(FAP/AFAP) which constitutes approximately 1% of cases and hereditary non-polyposis 
colon cancer (HNPCC or Lynch Syndrome) which constitutes around 5% of cases. The 
remaining 15-20% of the high risk population has a family history of CRC in close 
relatives without an identified genetic predisposition2.  
A higher incidence of familial and hereditary related risk for CRC is found in NL 
compared with many other populations3,4 and high risk screening clinics have been 
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established at multiple sites across the province. Correspondingly, a body of research into 
this population exists and stratification of the risk of developing CRC in NL is well 
described3,4,5,6.  Although there is a higher prevalence of high genetic risk CRCs in NL 
compared with other populations, the absolute number of these cases is smaller than the 
number who were at average risk before developing the disease. Therefore, it is crucial 
that an organized program be put in place to screen the average risk population. For the 
purposes of the screening program, an average risk individual will be defined as someone 
with no personal history of CRC or adenomatous polyps; no personal history of 
inflammatory colitis or Crohn’s disease; and no first degree relatives (parent, sibling, 
offspring) with CRC or adenomas.  
In addition to the average risk inclusion criteria, individuals targeted for this 
screening program will be between 50 and 74 years of age. It is well-established that the 
vast majority of sporadic CRCs, (over 90%), occur in those aged 50 or older7. The upper 
age limit is in keeping with the Canadian Association of Gastroenterology’s (CAG) 
recommendations on screening individuals at average risk for CRC8. CAG recommends 
that programmatic CRC screening should cease at 75 years of age and that the decision to 
screen individuals aged between 75 and 86 should be made on a case by case basis. The 
reason for this age cut-off is that the risk of harm from screening is increased in the 
elderly population. The risks of screening include complications related to bleeding, 
perforation and cardiorespiratory events.  Primary benefits of screening relate to number 
of life years saved. This decreases with increasing age. The additional benefit to 
individuals who have been enrolled in a screening program beyond 76 years of age is not 
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favourable9.   All other Canadian provinces with average risk screening programs have 
targeted the 50-74 age range. 
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1.2 Burden of Colorectal Cancer Nationally and Provincially 
According to the Canadian Cancer Statistics projections for 2014, an estimated 
24,400 Canadians (13,500 men and 10,800 women) will be diagnosed with CRC this 
year and 9,300 (5,100 men and 4,200 women) will die from it10. The lifetime 
probability of developing CRC is 7.5% for men and 6.3% for women. It is the second 
most common cause of cancer death for males and the third most common cause of 
cancer death for females. These statistics illustrate the extent of the national burden of 
this disease.      
Focusing on NL specifically, 320 new cases of CRC are projected for men in 
2014 (17.2% of all new cancer cases) and 230 new cases are projected for women (15.3% 
of all new cancer cases)10.  While projected counts are important and serve a variety of 
purposes, such as facilitating health care planning; age-standardized incidence and 
mortality rates also provide meaningful and useful information. Age-standardization is a 
process that adjusts for differences in age distributions among populations allowing for 
inter-jurisdictional comparisons. In Canada, the calculation of these rates is usually 
carried out using the 1991 Canadian population as the reference standard. Table 1.1 
shows the 2014 estimated age-standardized incidence rate (ASIR) of CRC by gender, for 
Canada and each of the provinces. ASIRs are presented per 100,000 of the population. 
The ASIR of CRC for men and women in NL is higher than for other provinces.   
Table 1.1 Estimated ASIRs for CRC by Gender and Province, Canada 2014 (Cases 
per 100,000) 
 Canada NL PEI NS NB QC ON MB SK AB BC 
Male 59 86 60 71 65 65 56 66 62 57 51 
Female 40 53 44 48 39 42 39 44 42 37 35 
Source. Canadian Cancer Statistics 2014. 
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In addition to incidence, mortality is an important indicator of the extent of cancer 
burden in a population. The number of estimated deaths in NL in 2014 from CRC is 140 
for men (16.5% of all cancer deaths) and 100 for women (14.9% of all cancer deaths)10. 
Estimated age-standardized mortality rates (ASMRs) are also available for 2014 and are 
presented in Table 1.2.  Men and women in NL have a higher mortality rate due to CRC 
when compared with other provinces. 
Table 1.2 Estimated ASMRs for CRC by Gender and Province, Canada 2014 (Cases 
per 100,000) 
 Canada NL PEI NS NB QC ON MB SK AB BC 
Male 22 39 23 29 21 24 21 23 22 20 20 
Female 14 22 18 17 14 16 13 15 13 12 13 
Source. Canadian Cancer Statistics 2014. 
Data in the Canadian Cancer Statistics publication, as outlined above, are very 
useful for supplying a description of projected cancer incidence and mortality rates.  
However, it must be acknowledged that the statistics reported are projections or estimates 
and are descriptive of the provincial population as a whole, as opposed to providing 
further breakdowns, such as cancer incidence and mortality by age. Reporting these 
statistics by age sub-group can elucidate differing trends in CRC burden across the 
lifespan.  
An analysis that was carried out using NL provincial cancer registry data for CRC 
(analysis was carried out ‘in-house’) provides a more in-depth look at the extent of CRC 
incidence in the province between 1983 and 2006 by age sub-group. Mortality data were, 
unfortunately, unavailable. Table 1.3 includes ASIRs by four age sub-groups and for all 
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ages combined, for select years between 1983 and 2006. As with the previous tables, 
rates are given per 100,000 of the population.  
Table 1.3 ASIR of CRC in NL by Age Subgroup for Select Years Between 1983 and 
2006 
Age Group Year Female Male Total Population 
 
15-29 
1983 4.5 0.9 2.8 
1994 0 0 0 
2006 0 0 0 
 
30-49 
1983 26.4 21.8 24 
1994 18.3 14.6 16.4 
2006 20.3 14.7 17.6 
 
50-74 
1983 176.5 199.1 187.8 
1994 159 237.6 196.9 
2006 170.3 276 222.3 
 
75+ 
1983 426.4 477.8 438.5 
1994 280.5 392.7 332.9 
2006 438 707.5 539.7 
All ages 
(including 
0-14) 
1983 64.5 69.2 66.2 
1994 50.7 70.7 60.2 
2006 60.9 92.9 75.2 
 
A benefit of examining CRC incidence by age sub-group is to enable the 
identification of those who are most at risk. The increase in CRC ASIRs from age 50 
onward suggests that 50 is an acceptable age to start screening in the NL population.  
Overall, the data in tables 1.1, 1.2, and 1.3 illustrate that CRC is a particularly 
salient health issue for this province, and that as age increases, so does the risk of 
developing CRC. These data support the decision to implement a CRC screening 
program in this province for the average risk, 50-74 year old population. 
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1.3 The NL Target Population  
Given that NL has the highest median age in Canada at 44.2 years11, there is a 
substantial proportion of the population that fits into the target age range for the screening 
program. While it is not possible to determine the exact size of the average risk screening 
population, it is possible to obtain an approximation of its size via census data. According 
to the 2006 census there are 245,735 males and 259,735 females in the province for a 
total of 505,470 people. Of this total population, there are 75,030 men and 76,995 women 
aged between 50 and 7412, which constitutes 30%, or almost one-third, of the full 
population. For the purposes of the screening program there are individuals who would 
be excluded from this total number for various reasons. For example, individuals at high 
genetic or familial risk for CRC should be targeted by the high risk screening program. 
The high risk program involves a provincial network of outreach offices in Grand Falls-
Windsor, Corner Brook and St. John's that work together to identify families at high risk 
of CRC. Members of high risk families, or carriers of gene mutations, are entered into 
this colonoscopy screening program. Other reasons for exclusion from the average risk 
screening program include receipt of a screening colonoscopy within the last five years 
which would render an individual ineligible to enroll in the screening program until a 
later date; or the presence of morbidities that make follow-up colonoscopy unfeasible. 
However, despite some ineligible individuals, it is likely that the majority of those aged 
50-74 belong to the average risk population.  
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1.4 Current Practices of CRC Screening in NL 
 In attempting to ascertain the status of CRC screening practices prior to 
implementation of an organized program, it became clear that no single data source could 
provide a robust picture. It was, therefore, necessary to triangulate information from 
various sources in an effort to understand the pre-program implementation state of CRC 
screening in this province. Sources of information included a research thesis, a provincial 
endoscopy access report, regional health authority laboratory databases and self-report 
data from the Canadian Community Health Survey (CCHS). It is acknowledged that the 
end result of collating these various sources of information does not provide a 
comprehensive summary of the screening practices in NL. Nonetheless, it does provide a 
triangulated snapshot of CRC screening activity. 
 A Master’s thesis carried out in 200913 aimed to determine whether 
gastroenterologists and general surgeons, the two clinical specialty areas responsible for 
performing endoscopy in NL, were knowledgeable about familial and hereditary CRC 
and associated risk factors and whether they followed best practice screening guidelines. 
Although this project largely focused on screening those in the high risk category, it also 
provided insight into specialist screening practices for the average risk population. The 
sampling frame for the study was all the gastroenterologists and general surgeons in NL 
registered with the College of Physicians and General Surgeons. Out of the eligible 
population of 43 physicians, 36 (83.7%) responded to the survey. Results showed that 
colonoscopy every ten years was the most commonly reported screening test and 
screening interval used for the average risk population.  Almost 70% of physicians 
reported using this screening modality for those at average risk. Fecal occult blood test 
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(FOBT) use for the average risk population was reported by 38.9% of physicians while 
flexible sigmoidoscopy or flexible sigmoidoscopy plus FOBT were each used by 5.6% of 
physicians (numbers do not add up to 100% as physicians could choose more than one 
option). These results suggest that colonoscopy may be the main screening modality that 
specialists use for screening the average risk population, which is not in accordance with 
the CAG guidelines8. FOBT, on the other hand, may be under-utilized. The proportion of 
average risk patients that were screened using each type of screening test cannot be 
determined from this thesis, rather, just the proportion of specialist physicians that report 
using each type of test in this population.  
Colonoscopies and flexible sigmoidoscopies are recorded in the various Meditech 
systems around the province making it possible to obtain the total number of procedures 
done in a given time period. This information is not entirely useful because indications as 
to whether the endoscopic procedure was performed for the purpose of screening, 
diagnosis or surveillance and whether it was performed on an average risk or high risk 
individual are not recorded. Similarly, when FOBT results are tested in the laboratory, 
neither the individual’s CRC risk status, nor indications for the test, are recorded. The 
guaiac fecal occult blood test (gFOBT) is still the most frequently used FOBT in the 
province. The fecal immunochemical test (FIT) will be broadly introduced with the 
advent of the screening program. There are two main pathways by which the gFOBT is 
distributed and analyzed. One is through the laboratory, whereby a physician will instruct 
their patient to obtain a gFOBT from the laboratory, complete it, and return it to the 
laboratory for testing. These results are recorded in a laboratory database. The other 
pathway is through physicians’ offices, for those physicians who keep gFOBTs in their 
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clinic and distribute them directly to patients. Because a result for gFOBT is obtained 
using a manually applied reagent, physicians can carry out this testing process in their 
own clinic environment. The results of gFOBTs that are tested in the clinic setting are not 
recorded in any administrative database. Essentially, there is no way of ascertaining the 
total number of gFOBTs that are distributed and subsequently tested in this province.  
With the above caveats considered, limited information on the volume of 
endoscopy and gFOBT carried out in NL is available through administrative databases. In 
2010, a province-wide assessment of the current state of the endoscopy system was 
undertaken14. This assessment, done to evaluate the demand and capacity of the existing 
endoscopy sites, reported on the total number of colonoscopies and sigmoidoscopies that 
were carried out in the province over a six-month period. The total number of 
colonoscopies was 7,898 and the total number of flexible sigmoidoscopies was 183. 
However, there were also categories listed for ‘sigmoidoscopy’ and ‘rigid 
sigmoidoscopy’ in the report although the distinction between flexible/rigid 
sigmoidoscopy and solely ‘sigmoidoscopy’ was not clarified. The count was 42 for rigid 
sigmoidoscopy and 1001 for sigmoidoscopy over the six-month period. Thus, the total 
number of sigmoidoscopies carried out was 1,226. If the assumption is made that an 
approximately equivalent number of scopes are carried out in any six-month period, then 
the total number of colonoscopies in a year would be 15,796 and the total number of 
sigmoidoscopies of any type would total 2,452. Thus, a year’s worth of colonoscopy and 
sigmoidoscopy would approximate 18,248 procedures. 
Ascertaining the number of laboratory-tested FOBTs was not as straightforward 
due to the fact that different regions of the province capture their data in different ways. 
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The following numbers were obtained from various laboratory databases by an Eastern 
Health employee and were provided in the following way: 
Table 1.4 Total FOBTs Analyzed in Laboratories, 2010 
Provincial Area Site Number Total 
Eastern Health Health Sciences 5584 10702 
St. Clare’s 1818 
Rural Avalon 3300 
Central Health Twillingate (73 @ 3 per 
person) 
219 1857 
Buchans (152 @ 3 per person) 456 
Green Bay (394 @ 3 per 
person) 
1182 
Western Health          Inpatient 678 13309 
         Outpatient 12631 
Labrador City  3456 3456 
TOTAL 29324 
 
As seen in Table 1.4, not all regions reported the data in the same way. For 
example, Central Health clarified that the total number of tests performed did not 
correspond to the total number of individuals tested.  One gFOBT consists of 3 separate 
smear cards and each card was recorded as a separate test although it was completed by 
the same person. It is not known for the other regions whether each documented test 
result corresponds to a unique individual or whether tests are recorded in a similar way to 
Central Health. If the latter is true then the number of FOBT results reported could 
correspond to up to two-thirds fewer people than tests.  
 
 
12 
 
Other sources, including the 2008 iteration of the CCHS provide an alternative 
perspective on the status of CRC screening in Canada and in NL; that of self-report. A 
Statistics Canada publication7 reported on up-to-date CRC testing practices for screening 
or diagnosis in Canadians aged 50 and over and determinants of screening, using data 
from the CCHS. Up-to-date testing was defined as FOBT in the past two years or 
colonoscopy / sigmoidoscopy in the past five years. The analysis showed that 
approximately 40% of Canadians ≥ 50 years reported that they had had up-to-date CRC 
testing according to the above definition. The reported rate for NL was 34%, which was 
not the lowest in the country, but ranked below the national average. Greater inter-
jurisdictional variability was observed for FOBT (10% - 42%) as opposed to endoscopy 
(11% - 30%). When the results for FOBT and endoscopy were looked at separately for 
NL, it was found that a higher percentage of respondents had undergone endoscopy 
(24.8%) compared with FOBT (15.6%).  
It seems counterintuitive to find higher self-reported endoscopy rates than FOBT 
rates given that the average risk population is larger in size than the high risk population 
and that FOBT is the recommended screening modality for average risk individuals. 
However, this finding reflects the responses of gastroenterologists and general surgeons 
in NL, more of whom preferred colonoscopy for screening average risk patients13.  
Possible implications of the CCHS findings are that only a small percentage of the 
average risk, screening eligible population are currently being screened (15.6% using 
FOBT), or that a higher number of the average risk population are being screened (up to 
34%), but potentially with an inappropriate screening modality given their risk level. 
Unfortunately, the risk status of respondents was not recorded in the CCHS database. 
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Regardless, it is concerning to find that only 34% of the 50+ population in NL report 
being up to date with CRC screening, and of those, only 15.6% were screened using 
FOBT. It is anticipated that the population-based average-risk screening program in NL 
will increase this percentage.  
In summary, the status of CRC screening by CRC risk level using FOBT or 
endoscopy is not well documented in NL, but from available information, endoscopy 
appears to be the preferred method. The precise number of FOBTs tested by the 
laboratory cannot be ascertained and there are currently no data available on the number 
of FOBTs distributed directly by family or specialist physicians that are returned to the 
clinic for testing. In the case of endoscopy procedures, it is possible to obtain a count of 
the total number of procedures for a given time period, but whether they were done for 
screening, diagnosis or surveillance and whether the patient was high risk or average risk 
is not known. A definitive evaluation plan with clear quality determinants and indicators 
as part of the CRC screening program should begin to rectify the paucity of information 
available on screening practices, at least for those in the average risk population who are 
tracked by the program.  
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1.5 Recommended Quality Determinants and Indicators for CRC Screening 
Programs 
Quality determinants and quality indicators are vital components of any screening 
program. Tracking activity at all points along the screening pathway will provide 
valuable information about how the program is operating and can highlight successes as 
well as areas where there may be room for improvement.  
In November 2008, the Canadian Partnership Against Cancer (CPAC) and the 
National Colorectal Cancer Screening Network (NCCSN) mandated a Working Group to 
identify quality determinants (including quality indicators) to be delivered in a formal 
report for use by organized CRC screening programs in Canada. These determinants / 
indicators were meant to consist of principles, processes and activities essential for 
maximizing the benefits of organized CRC screening in Canada while minimizing the 
potential risks15.  
The quality determinants identified in this report are based on a conceptual 
CRC screening pathway and are comprised of five key domains within the screening 
pathway: participation, screening, diagnostic follow-up, case management and program 
outcomes. This report focused on the average risk population, using a model of entry-
level FOBT with colonoscopic diagnostic follow-up for those with abnormal FOBT 
results. 
Quality determinants were proposed within each of the five domains for a total of 
the 20 indicators: a) Participation: participation, screening retention and utilization; b) 
Screening Test: positivity, positive predictive value for CRC and positive predictive 
value for adenoma; c) Diagnostic Follow-Up: colonoscopy completion, wait time to 
colonoscopy, wait time to pathological diagnosis, colonoscopy CRC detection, 
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colonoscopy adenoma detection, 30-day non-CRC-related hospitalization after follow-up 
colonoscopy and 30-day non-CRC mortality after follow-up colonoscopy; d) Case 
Management: wait time from screen-detected CRC diagnosis to initiation of treatment 
program; e) Outcomes: program CRC detection rate, interval CRC incidence, CRC stage 
distribution, CRC incidence, CRC mortality and non-CRC mortality. 
Each of these quality determinants are important and reflect significant points at 
which evaluation may occur along the screening pathway. One area that is not addressed 
in the context of this report is the pre-implementation phase of a screening program. It 
may be posited that pre-implementation does not comprise a part of the screening 
pathway because this pathway truly begins once a person is invited to participate in a 
screening program. However, it can also be argued that the pre-implementation phase of 
a screening program does constitute a part of the screening pathway and that it represents 
a key opportunity to understand more about the population that will be targeted for 
screening as well as the perspective of other stakeholders such as family physicians, 
nurse practitioners and relevant specialists. Developing a greater understanding of the 
target population, such as their knowledge about screening methods and intention to 
participate in the screening program, may identify particular issues or specific population 
subgroups that could benefit from interventions such as education, promotion or more 
practical support. Identifying issues at this stage could allow for a more efficacious use of 
resources and may help to enhance screening participation.  
Other jurisdictions have developed evaluation plans for their screening programs, 
albeit with a significant degree of variation in the detail. A selection of these will be 
described in the next section with particular attention paid to evaluation activity occurring 
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prior to the distribution of the screening test, and / or evaluation that focused on the 
screening target population’s perspective or other key stakeholders’ perspectives. 
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1.6 Program Evaluations from Other Jurisdictions 
1.6.1 Ontario 
Ontario was the first Canadian province to begin implementation of a population-
based CRC screening program. This entailed carrying out a pilot study followed by a 
broader program of implementation and evaluation. The Ontario FOBT Program was a 
twelve-month pilot program, carried out in 12 regions in Ontario between 2004 and 2005. 
It was designed to inform provincial policy on CRC screening16.  
A number of evaluative processes were undertaken prior to the distribution of 
FOBTs including a survey of FOBT awareness and behaviour administered to a sample 
of the target population in an effort to determine the decision-making stage of 
respondents about utilizing FOBT. Respondents were classified into one of five mutually 
exclusive stages of screening: never heard of FOBT, not considering FOBT, decided 
against FOBT screening, undecided about FOBT screening, and decided not to have 
FOBT screening. Random digit dialing was used to recruit survey respondents. A survey 
about direct mailing of FOBT kits was also carried out to ascertain the acceptability to 
potential screening program participants of the fundamental components of a centralized 
FOBT screening program. Primary care physicians were surveyed regarding their 
knowledge and behaviour with respect to FOBT screening and semi-structured open-
ended interviews explored practice barriers and facilitators regarding FOBT screening 
from the physician perspective. 
1.6.2 Manitoba 
The Manitoba CRC Screening Program was established in 2007 and subsequently 
carried out a 2.5 year pilot project (Phase 1) to assess the feasibility and acceptability of 
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an organized approach to CRC screening using the FOBT. The population targeted for 
Phase 1 was average risk individuals, 50 to 74 years of age, living in two selected RHAs 
and not up to date with CRC screening.  
No data collection occurred prior to implementation of the program; however, a 
survey was conducted after the administration of FOBTs. This was done to explore issues 
related to FOBT acceptability and factors that affected screening participation in 
Manitoba. Other evaluation activities included focus groups with people who received an 
FOBT from the program and interviews with key stakeholders to collect feedback on the 
first phase and implications for future phases of the program17.  
Like Ontario, Manitoba’s evaluation plan included an element of eliciting both the 
average risk population’s and physicians’ perspectives. However, in Manitoba, all 
activities were scheduled to occur after FOBT administration. 
1.6.3 United Kingdom 
 The UK carried out an FOBT pilot screening program between 2000 and 2002 
prior to national roll-out of FOBT screening in 2006. The pilot took place in two English 
health authorities and three Scottish health boards. Target participants were men and 
women aged 50 to 6918.  
 Evaluation activities included tracking participation rates and acceptability of 
screening according to various demographic characteristics (gender, ethnicity etc.); a 
psychosocial survey administered to both responders and non-responders in an effort to 
understand beliefs and attitudes about FOBT amongst the two groups; and, focus groups 
to qualitatively explore beliefs and views about CRC. Other evaluation activities focused 
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on further steps along the screening pathway including uptake and acceptability of 
colonoscopy, workload and impact on routine services. Like Manitoba, no data collection 
occurred until after administration of the FOBT kits. 
1.6.4 Australia 
 Australia began administration of an FOBT pilot in 2002, targeting those aged 55 
to 74. This program sought to assess the acceptability and feasibility of CRC cancer 
screening with the aim of informing whether and how to introduce a national, organized 
FOBT screening program19. Three sites from around Australia were selected for 
participation in the pilot.  
A number of diverse activities were undertaken as part of the evaluation process 
including a telephone-administered survey of knowledge, attitudes and practices of the 
target population in relation to CRC and CRC screening. The first administration of the 
survey was conducted prior to the commencement of the pilot, providing a baseline from 
which to evaluate the post-pilot survey data. A qualitative study was also carried out 
through interviews with people invited to participate at the three pilot sites. Objectives 
were to assess the relevant attitudes, opinions and behaviours that influenced 
participation or non-participation in the pilot. Focus groups and interviews were 
conducted with family doctors to explore the impact of the pilot program including the 
impact on GP satisfaction with their role in the pilot and strengths and weaknesses and 
possible barriers to participation in the pilot. Other quality determinants such as screening 
uptake, positivity rate, colonoscopy follow-up and impact on colonoscopy services were 
also measured.  
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1.6.5 Summary 
Many of these evaluation plans contain an element of assessing the average risk 
population’s perspective on CRC in general and on FOBT screening. Topics covered 
include knowledge of CRC and CRC screening, attitudes towards screening, barriers and 
facilitators to screening and intention to engage in screening. Each of the screening 
programs captured different elements of this information and measured it in varying 
ways. Most programs also attempted to capture the family physician and / or other 
stakeholders’ perspectives, but like the average risk population perspective, it was 
captured via different means and at various time points along the screening pathway. The 
final sections of this chapter will provide an overview of the aims and rationale for 
carrying out similar work at the pre-implementation phase of the screening pathway in 
NL and an outline for the remainder of the thesis.  
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1.7 Study Description and Rationale 
 
1.7.1 Study Aims 
Overview: This is a two-tiered study. Study one consists of a telephone survey of 
individuals at average risk for CRC, 50 - 74 years of age, and living in the following 
geographical areas: 1) New-Wes-Valley region, Lumsden, Greenspond  2) St. John’s  3) 
Marystown, Burin, and Grand Bank. Study two consists of a mail-out survey to all family 
physicians in the province. 
The primary aim of study one is to compare the screening intention of average 
risk individuals living in three distinct geographical regions: 1) a rural region with the 
presence of a familial cluster of high genetic risk CRC (high risk rural or HRR); 2) a rural 
geography without the presence of a familial cluster of high genetic risk CRC (average 
risk rural or ARR); and 3) an urban geography without the presence of a familial cluster 
of high genetic risk CRC (average risk urban or ARU). Secondary analysis will involve 
examining the relationship between other factors and reported screening intention of the 
average risk population. The primary aim of study two is to determine the level of family 
physician support for a population-based FOBT screening program for the average risk 
population in NL. Secondary objectives include describing the physician population and 
their CRC screening practices. The results of both studies will be used to gain a better 
understanding of potential uptake and support for the NL Colorectal Cancer Screening 
Program (NLCCSP).  
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1.7.2 Study Rationale 
The broad rationale for studying both the average risk population’s and family 
physicians’ perspectives prior to implementation of the screening program is that it may 
provide insight into how to administer the program to optimize screening uptake . The 
higher the level of screening participation, the more likely it is that the program will have 
an impact on reducing mortality due to CRC. There are possibly several points along the 
screening pathway at which opportunities to enhance screening uptake may occur, but the 
pre-implementation phase may present the best opportunity to be proactive as opposed to 
reactive about enhancing screening uptake.  
According to the screening evaluation reports of other more established 
programs16,17,18,19, efforts to elicit both the average risk population and family physician 
perspective are a standard practice in evaluation, regardless of the stage at which this 
endeavour occurs. In some evaluation plans, these activities occurred after the pilot round 
of screening was completed, before moving onto broader implementation, while in others 
it was done before any screening activity had started. 
  A statistical modeling exercise using the Population Health Model (POHEM) 
projected that a screening program with a 67% participation rate would reduce the CRC 
ten-year mortality rate by 16.7%, with an estimated cost effectiveness of $11,907 per life- 
year gained20. These results led the authors to conclude that CRC screening would be 
beneficial and cost-effective under the condition of achieving a 67% participation rate. 
However, a participation rate of 67% is a very high ideal to strive for with respect to 
population-based screening uptake.  
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Ascertaining how current participation rates measure up to this proposed standard 
is not straightforward, because, as Coombs et al. (2002)21 reported, it is difficult to 
synthesize the literature regarding CRC screening uptake due to differences in study 
methodologies and settings. Nonetheless, based on available information, they report that 
compliance rates typically range between 40%  and 50%. In the case of NL, it is probable 
that participation rates will begin below of this range and increase over time, as the 
program becomes more established. 
If no attempt is made to understand the average risk population’s intention to 
engage in screening, then the probable screening uptake rate cannot be estimated. 
Furthermore, in the absence of pre-implementation research, there will be no means of 
identifying vulnerable sub-populations within the average risk population, for example, 
those who report being less likely to engage in screening or those that report significant 
barriers to screening. Although certain demographic characteristics and other factors that 
impact screening have been studied, it is not known whether these barriers and facilitators 
are relevant in NL. Additionally, given the propensity to use endoscopy to screen for 
CRC in NL, as reported by gastroenterologists and general surgeons13, and by self-report 
data from the CCHS7, it is possible that awareness of FOBT as a screening test for CRC 
is quite low in the province, which could negatively impact uptake. By engaging the 
target population for screening it may be possible to understand more about these issues 
and to help develop interventions to address issues that exist. 
A similar rationale is proposed for eliciting the family physician perspective. 
There is considerable evidence to support the positive role that family physicians can 
play in screening uptake22,23. Even if screening kits are not administered through family 
 
 
24 
 
physicians’ clinics, physician attitude toward screening and their endorsement of it as a 
beneficial activity can impact the likelihood that their patients will engage in 
screening24,25. Additionally, doctors’ belief in the effectiveness of cancer screening tests 
has been shown to predict their use in clinical practice26. Collecting data on family 
physicians’ CRC screening practices in NL, their attitude toward whether FOBT is an 
effective screening test and their knowledge of current guidelines will not only generate 
new knowledge for this province in terms of the current state of FOBT screening, but 
may also act as a litmus test of how likely family physicians are to be supportive of the 
screening program. Depending on the outcome of this data collection, continuing medical 
education or other exercises in awareness-raising around the effectiveness of FOBT in 
reducing CRC mortality may be conducted.  
A final reason for conducting these investigations at the pre-implementation stage 
is that it allows for follow-up rounds of data collection at later stages, as the screening 
program is phased in. This leaves open the possibility for future research, beyond the 
scope of this thesis, on the intention-behaviour pathway and whether intention to screen 
or physician support for FOBT are reflected in actual screening participation and 
physician referral to screening. 
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1.8 Outline of Thesis 
Chapter one has provided an introduction to this thesis. The proposed screening 
program for the population at average risk for CRC in NL has been described along with 
the eligibility criteria for taking part in this program. The burden of CRC both nationally 
and provincially has been elucidated, as has the percentage of the provincial population 
that may comprise the average risk population. Furthermore, current screening practices 
in NL have been highlighted according to the best available information, and other 
screening evaluation plans have been reviewed. Finally, a broad overview of the study 
aims has been outlined and a rationale has been provided for carrying out a piece of 
research at the pre-implementation phase of the NLCCSP. The remaining chapters of the 
thesis will include a literature review (chapter two), research questions (chapter three), a 
description of the methodology and analysis plan (chapter four), results of the target 
population survey (chapter five), results of the physician mail-out survey (chapter six), 
and the discussion and conclusions (chapter seven).  
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Chapter Two 
Literature Review 
2.1 Overview of CRC 
2.1.1 Risk Factors 
Chapter one highlighted increasing age and familial or genetic predisposition as 
significant risk factors for CRC. In addition to these, there are a number of other risk 
factors for CRC, many of them modifiable. Each of these is briefly elaborated: a) 
Personal history of colorectal polyps or cancer: the polyp-carcinoma sequence in the 
development of CRC has been supported by several studies27,28,29,30. In addition, 
recurrence of polyps and CRC in those who have had previous occurrences has been 
highlighted as an issue21,31,32,33,34,35,36; b) History of inflammatory bowel disease: patients 
with long-standing inflammatory bowel disease have an increased risk of developing 
CRC37 c) Racial and Ethnic Background: varying rates of CRC may be seen in different 
racial and ethnic groups. For example, in the United States, blacks have higher incidence 
and mortality rates of CRC when compared with whites38; d) Personal History of Other 
Cancers: women diagnosed with uterine or ovarian cancer before age 50 are at increased 
risk of CRC, and women with a personal history of breast cancer have a slightly 
increased risk of colorectal cancer39; e) Diet: CRC appears to be associated with diets that 
are high in fat and calories, red and processed meats and low in fiber, vegetables and 
fruits. Researchers have also suggested that methods of cooking meats at very high 
temperatures (frying, broiling or grilling) create chemicals that might increase cancer 
risk21. In NL, pickled red meat (or salt meat) has been found to be significantly associated 
with an increased risk of CRC40; f) Sedentary Lifestyle / Physical Inactivity: physical 
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activity has been shown to reduce the risk of CRC41. It has been estimated that 12-14% of 
CRC could be attributed to lack of frequent involvement in vigorous physical activity42; 
g) Type II Diabetes: people with type 2 diabetes may have an increased risk of 
developing CRC. Both type 2 diabetes and CRC share some of the same risk factors 
(such as excess weight), but even after controlling for these, people with type 2 diabetes 
still appear to have an increased risk43; h) Obesity:  a meta-analysis of 31 studies 
illustrated a higher estimated relative risk of CRC for those who were obese compared 
with those who were in the normal weight range44. The same study showed evidence of a 
dose-response relationship between body mass index and CRC; i) Smoking: long-term 
smokers are more likely than non-smokers to develop colorectal adenomas and cancer45. 
A recent case-control study carried out in NL found that former and current smokers were 
at a significantly elevated risk for CRC compared with non-smokers46; j) Alcohol 
Consumption: a meta-analysis of 61 studies looking at the association between alcohol 
consumption and CRC concluded that there is strong evidence for an association between 
alcohol drinking of >1 drink per day and CRC risk47.  
These risk factors compounded with age and genetic factors likely play a role in 
contributing to the high burden of CRC found in NL. Lifestyle factors may be of 
particular relevance in this province.   
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2.1.2 Natural History of CRC 
 Most CRCs, regardless of etiology, arise from adenomatous polyps. A polyp is a 
grossly visible protrusion from the mucosal surface of the colon and may be classified 
pathologically as a non-neoplastic hamartoma (juvenile polyp), a hyperplastic mucosal 
proliferation (hyperplastic polyp), or an adenomatous polyp48. Only adenomas are clearly 
pre-malignant and only a minority of such lesions ever develops into cancer49.   
The adenoma-carcinoma sequence in the development of CRC has been supported 
by several studies and is generally well accepted2,27,28,29,30.  This sequence has a long 
natural history of approximately ten years28,30,49.  Colonic mucosa undergoes an orderly 
progression from the initial development of a polyp to the development of frank 
carcinoma. The evolution of normal colonic mucosa from a benign adenoma to invasive 
carcinoma has been associated with a series of genetic events, in which sporadic point 
mutations cause activation of proto-oncogenes and loss of tumor suppressor genes30. 
These progressive molecular genetic changes and resultant deregulation of cell growth 
and proliferation eventually lead to the development of invasive carcinoma.  
The lifetime risk of developing CRC in Canada is about 1 in 14 (7.1%) in men 
and 1 in 16 (6.3%) in women50. The rate of recurrence of adenomas among patients who 
have had a previous adenoma is generally higher than the prevalence of adenomas at 
initial colonoscopy31,51. Between 15% and 60% of patients who have had a polyp 
removed, develop a recurrence31,32,33,34,35,36. With respect to metastases, cancers of the 
large bowel generally spread to regional lymph nodes or to the liver via the portal venous 
circulation. The liver represents the most frequent visceral site of metastatic 
 
 
29 
 
dissemination50. In general, CRC rarely metastasizes to other sites without prior spread to 
the liver.  
2.1.3 Staging and Survival 
Cancer staging plays an integral role in cancer treatment. It forms the basis for the 
understanding of the disease at initial presentation. The American Joint Committee on 
Cancer (AJCC) utilizes a system that classifies the extent of the disease based on the 
extent of the primary tumor, the degree of lymph node involvement and whether there are 
distant metastases. The AJCC publish a cancer staging handbook that is revised every 6-8 
years to reflect advances in cancer care. The most recent cancer staging handbook was 
published in 201052. 
Staging is discussed in terms of clinical staging and pathologic staging. Clinical 
staging includes any information obtained about the extent of cancer before initiation of 
definitive treatment. It incorporates information from symptoms; physical examination; 
endoscopic examinations; imaging studies of the tumor, regional lymph nodes and 
metastases; biopsies of the tumor; and surgical exploration without resection. Pathologic 
staging is defined by the same diagnostic studies used for clinical staging, supplemented 
by findings from surgical resection and histologic examination of the surgically removed 
tissues51.  
Tumors, nodes and metastases (TNM) are grouped into anatomic stage / 
prognostic groups commonly referred to as stage groups. Groups are classified by roman 
numerals from I – IV with increasing severity of disease. Stage I denotes cancers that are 
smaller or less deeply invasive with negative nodes. Stage II and III define cases with 
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increasing tumor or nodal extent, and Stage IV identifies those with distant metastases at 
diagnosis.  
Stage at diagnosis has a significant impact on CRC survival. The overall relative 
survival rate for CRC has increased over the past twenty years mainly due to screening 
and treatment advances53,54.  Relative survival compares the observed survival for a 
group of cancer patients to the survival that would be expected for members of the 
general population who have the same characteristics such as sex, age and province of 
residence as the cancer patients. Relative survival rates in Canada for those with CRC are 
56% for men and 59% for women55.  
Although population-level relative survival broken down by stage is not available 
for the Canadian population at the current time, it is available for the US population. It is 
likely that Canadian trends would follow a comparable pattern as those in the US given 
that both are similarly developed countries with Westernized cultures and lifestyles. 
Surveillance Epidemiology and End Results (SEER) is a program of the National Cancer 
Institute which provides information on population-based cancer statistics in the US. 
They report the following distributions of stage at diagnosis and relative survival rates by 
stage for CRC from 2002-200856: 
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Table 2.1 Stage Distribution and 5-year Relative Survival by Stage at Diagnosis for 
2001-2007, All Races, Both Sexes 
Stage at Diagnosis Stage Distribution (%) 5-Year  
Relative Survival (%) 
Localized (Stage I and II)  39 89.9 
Regional (Stage III) 36 69.6 
Distant (Stage IV) 20 11.9 
Unknown 5 33.9 
    
The SEER data demonstrate that under half of all CRCs are currently diagnosed at 
Stage I or II (39%), when the disease is at its most curable. Five year relative survival for 
those diagnosed at Stage I or Stage II is very high at 89.9%. A similar percentage of cases 
are diagnosed at Stage III (36%), when the cancer has progressed to the regional lymph 
nodes. Five-year survival for Stage III is approximately 70% or twenty percentage points 
lower than when the disease is found at Stage I or II. Twenty percent of CRCs are 
diagnosed at Stage IV when distant metastases are involved. The five-year relative 
survival rate for those diagnosed with metastatic CRC is very low at around 12%.  
The large drop in five-year survival rate from Stage I / II to Stage IV illustrates the 
importance of detecting CRC early. Screening offers the opportunity to detect cancer at an 
earlier stage, or as can be the case with CRC, before pre-malignant polyps develop into 
cancer.  
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2.2 Rationale for Screening for CRC 
Preceding sections of this thesis have, in part, provided a rationale for why it is 
important to screen for CRC. However, while enhanced survival due to early detection 
and a considerable decrease in burden of disease are key factors supporting CRC 
screening, there are other elements to consider when determining the feasibility and 
efficacy of a screening program. There are many diseases for which one or more 
screening tests exist but for which evidence does not support screening on a 
programmatic, population-based level. One example of this is prostate cancer. The 
prostate specific antigen (PSA) test is a blood test used to screen for prostate cancer and 
there are contexts in which its use is both appropriate and beneficial. On a population-
based level, however, the evidence does not support the benefit of a PSA screening 
program. A Cochrane Review of a meta-analysis of five RCTs concluded that prostate 
cancer screening did not significantly decrease all-cause or prostate cancer-specific 
mortality57. 
In 1968, a document entitled Principles and Practice of Screening for Disease 
was published by the World Health Organization58. The content of this document is still 
relevant today and usefully outlines ten criteria for early disease detection which would 
render a disease appropriate for programmatic, population-based screening (pp26-27). 
Each criterion is listed below with a corresponding explanation of how CRC fits that 
criterion. 
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1) The condition sought should be an important health problem.  
Chapter one established that CRC is a significant health burden.  The incidence and 
subsequent mortality rates from CRC in NL are very high and show no indication of 
lowering. 
2) There should be an accepted treatment for patients with recognized disease. 
  There are a number of treatments available for individuals with CRC. These 
include surgical resection to remove the tumour, chemotherapy, and radiation. The latter 
two can be offered on an adjuvant or palliative basis. Treatment options depend on, 
amongst other things, the severity of disease at diagnosis and the site of the disease 
within the colon / rectum.   
3) Facilities for diagnosis and treatment should be available. 
 Facilities for diagnosis and treatment of CRC in NL are available at various sites 
across the province. Endoscopy is the main mechanism by which the presence of CRC is 
diagnostically confirmed. Endoscopy suites, where flexible sigmoidoscopy and 
colonoscopy are performed, are located in twelve different regions of the province.  
Treatments for CRC including chemotherapy, radiation, supportive care and palliative 
services are delivered by the Cancer Care Program. The program is responsible for four 
cancer centers, including the Dr. H. Bliss Murphy Cancer Center in St. John’s; and three 
regional centers in Gander, Grand Falls and Corner Brook.  Varying treatments are 
available at each of these sites.  
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4) There should be a recognizable latent or early symptomatic stage. 
  CRC does have a latent or early symptomatic stage in that the vast majority of 
tumours develop from adenomatous polyps. This implies that there is opportunity for 
primary prevention via the discovery and removal of pre-cancerous polyps. Additionally, 
there is scope for secondary prevention through the detection of early stage cancer, prior 
to regional lymph node involvement or distant metastases.  
5) There should be a suitable test or examination.  
Unlike many other diseases, which have only one main screening modality, several 
screening options exist for CRC. Flexible sigmoidoscopy and colonoscopy, which are 
used in the diagnosis of CRC, can also be used for screening purposes. Additionally, 
FOBT, a less invasive method that tests for the presence of hidden blood in the stool, is a 
well-established option in some provinces / countries. Less commonly used modalities 
for screening include computed tomographic colonography which images the colon, and 
the fecal DNA assay panel which tests the stool for the presence of genetic mutations 
linked to CRC. According to the 2010 CAG recommendations8, only FOBT (using either 
the FIT or high sensitivity gFOBT) or flexible sigmoidoscopy are proposed for 
programmatic screening.  
6) The test should be acceptable to the population.  
Availability of a screening test that is acceptable to the target population is a vital part 
of any screening program. Acceptability of a screening test is dependent on many factors 
including personal preference, invasiveness of the test, perceived accuracy of the test, 
costs of the test (including costs in terms of time to prepare for and perform the test) and 
perceived benefits of the test. It is not likely that one test will suit all individuals in a 
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population. Yet, due to the number of options available for CRC screening, it may be 
more likely that an individual will find a test that is acceptable to them. The non-invasive 
nature of fecal occult blood testing may be an attractive feature to some individuals. 
7) The natural history of the condition, including development from latent to 
declared disease, should be adequately understood. 
 
As explained in section 2.1.2, the natural history of the development of CRC is 
reasonably well understood. Polyps generally arise from the colonic mucosa or the 
innermost layer of the colon. Progressive molecular genetic changes and resultant 
deregulation of cell growth and proliferation eventually lead to CRC. The time line 
between the start of a pre-malignant polyp and its subsequent development into frank 
carcinoma can take up to ten years14,18,38. 
 
8) There should be an agreed policy on whom to treat as patients.  
Any screening program should target those who are most at risk for the disease in 
order to maximize the impact of the program and to ensure the most efficient use of 
resources. CRC screening efforts in the average risk population usually target those aged 
50 to 74. This decision is supported by available evidence and guidelines7,8. All provinces 
that have implemented screening programs to date have focused on this age range.  
9) The cost of case-finding (including diagnosis and treatment of patients 
diagnosed) should be economically balanced in relation to possible expenditure 
on medical care as a whole.  
 
The cost-effectiveness of CRC screening has been well-studied. A 2010 review by 
Lansdorp-Vogelaar et al.59 of all of the major screening modalities reported that the cost-
effectiveness ratios for all established screening strategies (defined in the paper as 
colonoscopy, flexible sigmoidoscopy and gFOBT) were less than $50,000 per life year 
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gained. An intervention that provides an additional life year at an incremental cost of 
$50,000 or less is deemed acceptable in most industrialized countries.  
When the established strategies were compared against each other, no strategy 
was consistently found to be the most effective or to have the best incremental cost ratio. 
When the newer immunochemical-based test was compared to the guaiac-based test, the 
results were mixed. Approximately half of the studies concluded that the 
immunochemical test was a cost-effective strategy, while the other half suggested that the 
guaiac test was superior. This result was mainly dependent on the price difference 
because the guaiac test is less expensive. Fecal DNA  was shown to be cost effective 
compared to no screening but less effective than established tests, while computed 
tomographic colonography was been estimated to be more expensive, and in many cases, 
less effective than colonoscopy.  
 
10) Case-finding should be a continuing process and not a “once and for all” project.  
 
  Guidelines exist for the appropriate interval between screenings for most of the 
modalities available. With respect to programmatic screening, the CAG recommends 
annual or biennial screening, (dependent on available resources), if using FOBT and 
screening at ten year intervals if using flexible sigmoidoscopy. The CRC screening 
program for the average risk population in NL will offer biennial fecal immunochemical 
testing to those aged 50 – 74, who fit the average risk criteria. 
Based on the ten comprehensive criteria listed above, a case can be made for the 
feasibility of screening for CRC, and more specifically, screening for CRC using FOBT.  
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2.3 Review of Fecal Occult Blood Testing 
The screening test that will be used in the NL average risk screening program is the 
FIT. FIT belongs to a category of tests called FOBTs which are designed to detect hidden 
or small quantities of blood in a stool sample. FOBTs are not diagnostic for cancer; rather 
they are used to select individuals for more definitive diagnostic procedures including 
colonoscopy60. There are two main types of FOBT, the FIT and the gFOBT. A systematic 
review of CRC screening carried out for CPAC provides a thorough description of both 
tests61. 
Guaiac tests detect hemoglobin peroxidase activity in the feces. It is not specific to 
the activity of human hemoglobin and requires dietary and medicinal restrictions for 
testing. For example, red meat or fruits and vegetables high in peroxidase activity can result 
in false positive tests. Aspirin and other medications can also lead to false positives due to 
other sources of gastrointestinal bleeding. Conversely, high doses of vitamin C may lead 
to false negatives. In order to complete a gFOBT, samples from two to three different bowel 
movements are smeared onto test cards using a spatula. If any of the samples turn blue 
when mixed with a reagent, the test is positive. Exact definitions of positivity may vary.  
FITs detect the globin component of human hemoglobin using a monoclonal or 
polyclonal activity. They are specific to human hemoglobin, eliminating the need for diet 
or medicinal restrictions. Some FITs use a spatula method while others involve pushing a 
brush or a probe into the stool and sealing it in a tube. Both gFOBTs and FITs can be 
processed in a physician’s office or a laboratory. FIT analysis may be carried out with 
automated instrumentation and the cut-off value or threshold for positive tests may be user-
defined. 
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CAG endorses the use of either type of FOBT for programmatic screening of 
average risk individuals, but states that FIT is preferred8. A review of the literature around 
both types of FOBT reveals that gFOBT has been in existence substantially longer than 
FIT. Three large-scale randomized controlled trials (RCTs) on the gFOBT have 
demonstrated that CRC is detected at an earlier and more curable stage among patients 
screened by gFOBT than among unscreened patients62,63,64. Over an eight to thirteen year 
period these studies were able to demonstrate a 14% to 18% reduction in CRC deaths with 
biennial screening62,63 and a 33% reduction in deaths with annual screening64. A further 
follow up to one of these trials65 found that the use of either annual or biennial FOBT 
screening significantly reduced, not only mortality, but incidence of CRC. The reduction 
in incidence likely resulted from the detection and removal of pre-malignant adenomatous 
polyps.  
The three major RCTs that demonstrated the effectiveness of FOBT in reducing 
CRC mortality were initiated between 1975 and 1985. The main type of FOBT test 
available at that time was the gFOBT, and thus, the strongest evidence for a reduction in 
mortality of CRC through FOBT screening is based on utilization of the gFOBT. Since 
that time, several advances have been made in fecal occult blood testing including the 
development of the FIT which was described earlier. For many researchers and clinicians, 
the FIT may have more desirable properties when compared with the gFOBT; including 
the fact that only one bowel movement may be necessary to obtain an adequate sample, 
no dietary restrictions are required, and results can be analyzed via an automated 
instrument. The fact that there are currently no RCTs published demonstrating the 
effectiveness of the FIT in reducing mortality from CRC is a limitation of this test. 
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Nonetheless, it may be posited, based on the properties of the FIT, and given that its 
mechanism of use is analogous to that of the gFOBT, that population screening for CRC 
using the FIT test would result in a reduction in mortality and perhaps also in the 
incidence of CRC.  
Despite the lack of RCT-level evidence on the impact of FIT on CRC mortality, 
studies have been carried out comparing the performance of the gFOBT and the FIT. 
Characteristics compared include positivity rate, sensitivity, specificity, positive 
predictive value and participation rate. A study performing both gFOBT and FIT in 
parallel on the same stool samples found an overall positivity rate of 6.7% for the gFOBT 
and 11.8% for the FIT66. Patients in this trial were followed up with diagnostic 
colonoscopy and a sensitivity of 74.2% was reported for the gFOBT compared with a 
significantly higher sensitivity of 87.1% for the FIT (p = 0.02). Sensitivities for screening 
advanced adenomas and early stage cancers specifically (which would be the primary 
foci of a screening initiative) were also significantly different at 23% for gFOBT and 
40.5% for FIT (p < 0.001). With regard to specificity, gFOBT was found to have a 
significantly higher specificity compared to FIT for cancers of all stages (95.7% vs. 91%, 
p < 0.001) and for advanced adenomas (97.4% vs. 94.2%, p < 0.001). 
An RCT comparing gFOBT, FIT and flexible sigmoidoscopy as screening 
modalities in an average risk population found varying rates of participation for each type 
of test67. The FIT had the highest participation rate at 61.5%, followed by 49.5% for 
gFOBT, and 32.4% for flexible sigmoidoscopy. Positivity rates showed a similar trend as 
in the previously reported study with the lowest positivity rate observed for gFOBT 
(2.8%), followed by 4.8% for FIT and 10.2% for flexible sigmoidoscopy. After adjusting 
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for age and sex, FIT detected more advanced adenomas than gFOBT, [OR = 2.0, 95% CI 
1.3 - 2.3].  Diagnostic yield of advanced neoplasia per 100 invited subjects was 
significantly higher for FIT [1.5, 95% CI 1.2 - 1.9] than for gFOBT [0.6, 95% CI 0.4 - 
0.8], p < 0.0001.  
Hoffman et al. (2010)68 also found a significantly higher rate of screening or 
participation for patients assigned to FIT (68%) compared with those who were assigned 
to gFOBT (55%) p = 0.01. Stepwise regression showed that adherence to screening was 
associated only with receiving FIT versus gFOBT [OR = 1.56, 95% CI 1.04 – 2.32]. For 
patients who completed both tests, 62% reported a preference for the FIT, 12% preferred 
the gFOBT and the remainder were neutral. Respondents indicated problems with the 
dietary and medication restrictions for gFOBT and the majority found it easier to perform 
FIT. 
An RCT of average risk patients, in addition to finding that FIT had favourable 
characteristics when compared to gFOBT, (participation, positivity, detection rates for 
advanced adenoma and cancer), found that five patients with a negative gFOBT had an 
interval cancer, detected within two years of testing69. This was discovered by conducting 
a review of cancer registry data. These cancers were likely missed by gFOBT. Tumours 
were found in various anatomic sites in the colon including the sigmoid colon, the 
descending colon, the ascending colon and the cecum. The registry review did not yield 
any missed cancer results in those with a negative FIT. Overall, FIT detected cancer and 
advanced adenomas better than gFOBT by both intention to screen analysis [OR = 2.9, 
95% CI 1.59 - 4.57, p = 0.001] and per protocol analysis [OR = 3.16, 95% CI 1.8 -5.4, p 
< 0.001].  
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Based on the CAG endorsement for the FIT and the available evidence supporting 
its higher sensitivity, PPV and screening adherence rates, it was decided that this test 
should be utilized in the NL screening program. Lower specificity rates on the FIT 
compared with the gFOBT are acknowledged, however, on balance, the FIT appears to be 
the more effective test. Almost all Canadian provinces use the FIT test in their respective 
average risk screening programs (i.e. Alberta, British Colombia, New Brunswick, Nova 
Scotia, Prince Edward Island, Quebec and Saskatchewan).  
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2.4 Screening Behaviour 
Establishing that CRC is an appropriate disease for which to screen on a 
population-level is an important element of making the case for the feasibility of 
launching a screening program for the average risk population in NL. Demonstrating that 
the FIT screening test is an appropriate and effective test for this purpose is equally 
important. These two points can be made relatively empirically and according to a set of 
discrete criteria. However, it is insufficient to focus solely on the nature of the disease or 
the screening test in question. The population for whom the screening program is 
intended must also be investigated. Desirable results may be achievable (i.e. a reduction 
in incidence or mortality) by using a certain test, and administration of the test may be 
easy and straightforward, but if no one has heard of the test or has any intention of using 
it, the screening program will not be successful. A logical place at which to start this 
investigation of the target population for screening is before the screening program has 
been implemented. This offers the opportunity to learn about and address possible 
barriers and challenges before they occur, as opposed to trying to rectify them in 
hindsight. This is not to say that additional issues will not arise as full implementation 
gets underway, but allows for a proactive approach to implementation.  
Initiating this investigation at the pre-implementation stage, to a certain extent 
dictates the way in which questions must be asked. This is not seen as a shortcoming of 
the investigation, rather it simply provides a focus for the way in which the study must be 
framed. Due to the unavailability of information regarding the average risk population’s 
familiarity with fecal occult blood testing or prior CRC screening behaviour using FOBT, 
these questions must be asked. Whether a person intends to complete an FOBT is not a 
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valid enquiry if they do not know what it is; it cannot be assumed the participant has any 
prior knowledge. Consequently, awareness and previous participation in fecal occult 
blood testing will also be explored in the average risk population, along with intention to 
participate in screening. 
2.4.1. Behavioural Theory 
There exists extensive literature on the subject of behaviour and behavioural 
intention, for example, whether individuals engage in a host of health preserving or 
safety-enhancing behaviours and whether they abstain from a variety of negative or risky 
behaviours. Health behaviour related fields have several examples of this type of 
research, often utilizing a theory-based approach in an attempt to better understand health 
behaviour and to develop behaviour change interventions. The Health Belief 
Model70,71,72, the Theory of Planned Behaviour73,74,75 and the Transtheoretical 
Model76,77,78 are all theories commonly utilized in this type of research.  
A useful review on theoretical behavioral change models and their relationship to 
either participation in CRC screening or intention to participate in CRC screening was 
done by Kiviniemi et al. (2010)79. The objectives of the report were to provide an 
assessment of which theoretical models and their related constructs have and have not 
been studied, to explore the sufficiency of the examination of the constructs in relation to 
CRC screening, and to summarize the association between these constructs and CRC 
screening behaviour. Constructs examined that related to one or more behaviour change 
models included severity, susceptibility, benefits, barriers, self-efficacy, attitude, social 
norms, perceived behavioural control, response efficacy, decisional balance and 
processes of change. Of the constructs examined, it was found that benefits, barriers and 
 
 
44 
 
perceived susceptibility have been relatively well-examined, while less evidence was 
available for the other constructs. The Health Belief Model was the only theory that had 
all its underlying constructs investigated in a single study, suggesting that the underlying 
constructs of most theories were only partially investigated.  
This review also examined how well the evidence in the literature supported the 
predictions made by the theoretical models. It was found that for each of the investigated 
constructs, the majority of the studies supported the hypotheses derived from the models. 
In some cases no relationship was found between the construct and behaviour or 
behavioural intentions, however, it was uncommon to find that the relationship observed 
was opposite to what was predicted.  
The review concluded that there are limitations to this body of literature, 
including relative scarcity of research coverage for some decision-making constructs, and 
piecemeal selection of constructs from models. Additionally, it was observed that there 
was variation in how concepts were conceptually and operationally defined. Thus, it can 
be said that behavioual theories do make an important contribution to the understanding 
of screening participation or intention to participate in CRC screening, but that there is 
still work to do in this field.  
2.4.2 Search Strategy 
In acknowledging the contribution of behavioural theories to CRC screening, it is 
essential to highlight that other factors also play a role in screening participation and 
screening intention. For example, demographic, socio-economic, geographical, and 
awareness/knowledge factors. This thesis will focus on these latter types of factors and 
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their relationship to reported screening intention in the target population for FOBT 
screening in NL.  
A detailed literature review of these types of studies was conducted to provide a 
rationale for the content of the questionnaire developed for the average risk population 
survey as well as to generate hypotheses regarding the characteristics that may make 
individuals in the average risk population more likely to report an intention to engage in 
screening. A search was conducted through the Memorial University Health Sciences 
Library ‘Health Databases’ journal repository. PubMed and CINAHL were the primary 
databases that returned relevant articles. Search terms pertinent to studies on CRC 
screening intention and articles written in English language only were included in the 
search. It is possible that this may have introduced language bias into the search and 
selection of articles80. Of particular concern is that papers reporting negative results are 
more likely to be published in non-English-language journals81.  However, the research 
examining this issue is conflicting in that this bias is not consistently found82,83. Article 
abstracts were read to determine whether the study reported one or more demographic, 
socio-economic, geographical or awareness/knowledge factors in relation to intention to 
participate in CRC screening. The reference section for all relevant articles was hand 
searched for additional relevant studies.  The literature search was not restricted by date 
to ensure the research reviewed would give a comprehensive overview of the topic but 
the main focus was on more recent articles (2000 onwards). It was found that there was 
literature available on demographic, socio-economic and awareness factors, and to a 
lesser extent geographical factors, however availability for of these all factors was 
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somewhat limited. For this reason, relevant studies that looked at these factors in relation 
to actual participation in screening, in addition to intention to screen, were included.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
2.4.3 Determinants of Intention to Screen 
 1. An Australian study by Duncan et al. (2009)84 looked at demographic 
associations with stage of readiness to screen for CRC using either FOBT or colonoscopy 
in an urban population aged 50-74 (n = 664) via mail-out survey. This survey was sent to 
1,250 individuals randomly selected from the Australian electoral roll residing in specific 
urban areas. The response rate was 55%. The majority of respondents reported being 
either in the pre-contemplation stage, ‘have not thought about screening’ (35%), or the 
action stage, ‘have prepared to screen for CRC or have already screened for CRC’ 
(31.1%). The remainder were distributed amongst the contemplation stage, ‘have thought 
about screening but have not made a decision’, (18%), the rejection stage, ‘have thought 
about screening for CRC and decided not to’ (4%), and colonoscopy intention, ‘have 
decided to screen with a modality other than FOBT’ (11.9%). The author reported that 
women and those in younger age subgroups of the survey population were less likely to 
be in the action phase than men and those in older age subgroups [χ2(4) = 9.59, p <0.05] 
and [Fishers exact test= 16/042, p <0.001] respectively. There was a larger proportion of 
the survey population between the ages of 60 and 64 in the rejection stage but a 
considerably smaller proportion between the ages of 65 and 70. These findings do not 
indicate a linear association between increasing age and likelihood of screening rejection. 
In fact, the total proportion of those who reported rejecting CRC screening was very low. 
 The generalizability of this study was somewhat limited by the sub-group sizes 
(broken down by screening intention). The rejection stage was only selected by 4% of 
individuals. Because the survey was conducted on a mail-out basis, the number of true 
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rejecters may have been underestimated due to their lack of participation. Sampling from 
an urban population only may also have imposed limitations on the generalizability of the 
results to the broader Australian population. The random sampling of participants for this 
study is a strength.  
 2. Weinberg et al. (2009)85 surveyed 318 American women aged 50+ who were at 
average risk for CRC and non-compliant with screening. All women fitting the eligibility 
criteria were selected from an electronic medical record and contacted by telephone. 
After consent was obtained, respondents were asked to complete a 75-item survey; the 
response rate was 49%. Respondents demonstrated a high level of basic knowledge about 
CRC and CRC screening, however, 65.7% stated they had no need and / or no plans to 
undergo CRC screening while 34.3% reported plans to be screened. This study found no 
significant association between screening intention and CRC knowledge. An association 
was found between increased age and lower intention of being screened [OR = 1.12, 95% 
CI = 1.00 - 1.24, p <0.03]. This trend differed from the finding of the previous study, as 
did the finding that the majority of respondents reported no intention to undergo 
screening. Sampling for this survey was not random and the sample was comprised 
largely of employed and well-educated women. It is not known whether it is possible to 
extrapolate these results to other population sub-groups or to men. 
 3. Indigenous Australians ≥ 35 years of age86, (n = 93), were recruited by 
convenience sampling and administered a face-to-face interview regarding CRC 
knowledge and screening intention.  It was found that neither gender nor age were 
associated with intention to undergo FOBT screening. Marital status was associated with 
the intention to undergo screening in that those who were married or de facto married 
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were more likely to report an intention to screen than those who were widowed or 
divorced [OR = 5.96, p <0.0001]. Those who were employed [OR = 3.14, p = 0.022], 
were more educated [OR = 2.62, p = 0.043], had an income higher than $20,000 [OR = 
2.79, p = 0.048], who had participated in any cancer screening in the past [OR = 3.83, p = 
0.003], knew someone in their family with cancer [OR = 2.71, p = 0 025], had ever heard 
of CRC before [OR = 2.72, p = 0.048] and had ever heard of a CRC screening test [OR = 
3.3, p = 0.027] were also more likely to report an intention to undergo screening. 
Awareness of FOBT was low in this study with only 14% knowing what an FOBT was. 
Even after being given a detailed explanation and description of the FOBT, only 30% 
said they had heard of the test. However, unlike the Weinberg study, knowledge or 
awareness of CRC was positively associated with intention to undergo screening and 
unlike the Duncan study; no differences were found between gender and intention to 
screen. Limitations of this study include a fairly small sample size and a non-random 
sampling strategy. Recruitment occurred in urban centres only, so viewpoints of 
Indigenous people living more remotely may not be not be represented.  
 4. Data from the Korean National Cancer Screening Survey yielded differing 
results when compared with the previous studies on intention, illustrating that different 
factors appear to affect CRC screening intention in different populations. This was a 
population-based, interview-administered survey of a nationally representative sample of 
Koreans. Results on screening intention were reported for the subset of respondents aged 
≥ 50 years (n = 955)87. In this study, positive intention to screen was reported by 34.1% 
of respondents. The odds ratio for intention to screen was significantly higher in younger 
adults, [OR = 4.96, 95% CI 2.41 – 10.21] for those aged 50-59 and for those aged 60-69 
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[OR = 2.77, 95% CI 1.37 – 5.61] when compared with respondents aged 70+ years. 
Findings were non-significant for gender, education level, household income, marital 
status, residence (towns, middle & small sized cities, large cities) and family cancer 
history. Sampling this study was random and representative on a national level. 
 5. Sifri et al. (2010)88 conducted a telephone survey in the US with respondents 
aged 50 -74 years (n = 1515); the response rate was 58.7%. Survey items included 
sociodemographic background, perceptions about CRC screening and decision stage for 
screening. Screening decision stage was distributed among participants as follows: 
‘decided against’ (2%), ‘never heard of’ (8%), ‘not considering or undecided’ (41%) and 
‘decided to do’ (51%). Compared with other studies there was only a small population 
that had never heard of the screening test and over half of the population reported that 
they had decided to get screened. Multivariate analysis showed that participants who 
were female [OR = 2.18, 95% CI = 1.39 - 3.42, p = 0.001] and had prior cancer screening 
[OR = 2.81, 95% CI = 1.67 - 4.71, p < 0.001] were more likely to be in the ‘not 
considering or undecided stage’ as opposed to the ‘never heard of’ stage. Participants 
who were younger (<60 versus 60+) [OR = 0.64, 95% CI = 0.51, 0.81, p < 0.001] and 
had prior cancer screening [OR = 1.43, 95% CI = 1.14, 1.79, p = 0.002] were more likely 
to be in the ‘decided to do’ stage than the ‘not considering or undecided’ stage. All 
respondents for this survey were recruited from a single family practice clinic, implying 
that there could be a degree of homogeneity in this sample which would limit 
generalizability.  
 6. Tong et al. (2000)89 carried out a randomly sampled telephone survey in 
Queensland, Australia. Respondents were aged 40 to 80 years (n = 884). Questions were 
 
 
50 
 
asked about screening intention in the context of whether or not respondents would 
intend to participate in screening if a recommendation to screen was made by a doctor or 
health authority. The response rate was 77.8% and positive intention to screen was 
reported by 77.5% of the sample.  Bivariate analysis showed that younger age (40-59), 
being married or de facto married, being more highly educated, employed and having a 
higher household income were all associated with a greater likelihood of screening 
intention. Significant associations were not found between screening intention and 
knowledge of a friend or relative with CRC, nor number of first degree relatives with 
CRC. In a multivariate analysis using multinomial logistic regression likelihood ratio chi-
squared tests it was found that only age [χ2 (6) = 15.0, p = 0.02] and education [χ2 (8) = 
19.4, p = 0.01] remained significant. The high reported positive screening intention in 
this study could have been influenced by the way the question was worded. Respondents 
were queried about whether they would screen in the setting having received a 
recommendation by a doctor or health authority. This may have biased the responses 
toward positive intention.  
7. A second publication by Tong et al.90 (2006) explored screening intention in the 
same study sample. However, this time they considered the association between 
screening intention and knowledge, attitudes, beliefs and behaviours. Findings relevant in 
the context of this thesis included that only 28% of respondents reported an awareness of 
FOBT and these respondents were more likely to express a positive intention to screen (p 
= 0.04). Additionally, only 7.6% of respondents reported prior participation in FOBT. 
Those who had previously participated in FOBT were much more likely to express an 
intention to screen than those who had not (p < 0.01). 
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8. A demonstration project on utilizing FOBT screening in a rural setting was 
conducted by Janda et al. (2003)91. The target population included men and women aged 
50-74 living in a rural area of Northern Australia (n = 604). The survey was conducted 
via telephone. When asked how likely they were to participate in FOBT screening in the 
future 89 (15%) participants responded ‘very likely’ and an additional 231 (38%) 
indicated that they were ‘likely’. Univariate analysis found that intention to screen was 
similar for men and women and for those living with or without a partner. Those aged 70 
years or older were significantly less likely to report an intention to screen than those 
younger (p = 0.008). Those with college or university education were more likely to state 
that they would ‘very likely’ participate in future FOBT screening when compared to 
participants with lower educational levels (p = 0.01). Just over half of participants had 
heard of FOBT (52%), only 18% had ever had an FOBT. Participants with a family 
history or knowledge of someone with CRC were more likely to express positive 
screening intent. Multivariate logistic regression analyses found that prior use of FOBT 
[OR = 3.2, 95% CI = 1.8 - 5.5] was the strongest independent significant correlate of 
intention to screen. Age showed the strongest inverse relationship with older people (70-
74 years) less likely to express an intention to screen [OR = 0.5, 95% CI = 0.3 - 0.9]. 
Compared to those knowing no one with CRC, knowing someone, whether family or not, 
increased the likelihood of screening intention [OR = 1.5, 95% CI = 1.0 - 2.2]. Phone 
numbers for this study were randomly sampled from a database of listed residential 
numbers. Those with an unlisted number or without a telephone would not have been 
reached using this methodology and, as such their views were not represented. The target 
population for this survey was rural-dwelling respondents. 
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9. Gregory et al.92 (2011) looked at demographic and social cognitive predictors 
of intention to screen for CRC and actual screening participation. People aged 50 to 74, 
residing in an urban area of South Australia, were surveyed via mail-out using the Bowel 
Cancer Screening Questionnaire (BCSQ). The BCSQ was designed to determine a 
participant’s intention to screen using FOBT and to collect information on demographic, 
social cognitive and social ecological measures. The response rate was 56% and positive 
intention was reported by 7.6% of respondents. People who returned the questionnaire 
were sent a FIT four weeks after the questionnaire had been received. Intention to screen 
was measured by six stages of readiness to screen. Only those who were in the pre-
contemplation, contemplation and preparation stages were included in the analyses. 
Those in the action, rejection or colonoscopy intention groups were excluded because the 
study was interested in a relatively naïve sample with respect to screening intention. The 
sample size was 376 individuals with full survey data who were able to complete the FIT 
(pre-contemplation n = 215, contemplation n = 110, and preparation n = 51). Of the entire 
sample, 192 completed a FIT and 184 did not. In the univariate analysis, intention to 
screen was significantly associated with gender [χ2 = 7.77, p < 0.05], past screening for 
cancer [χ2 = 11.82, p < 0.01], knowing someone who has had CRC [χ2 = 12.68, p < 0.01], 
born in Australia [χ2 = 13.15, p < 0.05] and English speaking [χ2 = 6.78, p < 0.05]. Actual 
participation in the screening offer was significantly associated with just two 
demographic variables, past screening for cancer [χ2 = 6.35, p < 0.05] and knowing 
someone with CRC [χ2 = 8.22, p < 0.01]. Age, marital status, employment status, 
education level and socio-economic status were not found to be significant factors in 
stage of readiness to screen or screening participation in the univariate analysis.  In a 
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multivariate analysis for intention to screen there were five significant predictors of stage 
of readiness to screen for CRC. People who been screened for cancer in the past [OR = 
1.38, 95% CI = 1.04 - 1.81, p = 0.02], perceived low barriers and high benefits to 
screening [OR = 0.78, 95% CI = 0.70 - 0.94, p = 0.01], believed that good health was not 
due to chance [OR = 0.84, 95% CI = 0.75 - 0.94, p = 0.01], people who believed 
themselves to be susceptible to CRC [OR = 1.28, 95% CI = 1.15 - 1.42, p = 0.01], and 
had higher perceived knowledge about CRC and screening [OR = 1.11, 95% CI = 1.01 - 
1.24, p = 0.05] were more likely to be in a higher stage of readiness to screen. There were 
only two significant predictors of actual participation in a multivariate model. People 
who had known someone with CRC [OR = 1.26, 95% CI = 1.02 -1.57, p = 0.04] and 
perceived low barriers and high benefits to screening [OR = 0.86, 95% CI = 0.79 - 0.95, p 
= 0.01] were more likely to participate in the screening offer. While there was some 
overlap between predictors, this study supports the proposition that predictors of intention 
to screen for CRC and actual CRC screening are not the same.  
10. A Canadian study by Ritvo et al.93 (2009) conducted a telephone survey of 
people in Ontario aged 50+  to test awareness of FOBT for CRC screening and readiness 
to be screened using FOBT. In total, 1013 people were surveyed for a response rate of 
69%. It was found that awareness of FOBT was low with 46% of women and 55% of 
men never having heard of it. Univariate analysis showed that women were more likely 
to have heard of FOBT [z = -2.90, p = 0.0045], as were people who were married or 
living as married [z  = -1.67, p = 0.11], and those who had completed college or higher 
level education [z = 3.96, p = 0.13]. Overall, only 17.1% of the sample reported a 
positive intention to screen. Of the 45% of men who had heard of FOBT, over half (26%) 
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were not considering screening. The same was true of women with 54% having heard of 
the test and 26% not currently considering FOBT. Among those who had heard of FOBT, 
men [z = 2.20, p = 0.35] and married people [z = -2.14, p = 0.27] were more likely to be 
actively considering screening. Multiple logistic regression showed that women with 
college-level or higher education were far more likely to have heard of FOBT than men 
with a similar education level [OR = 2.20, 95% CI = 1.5, 3.3] or less educated women. 
Among those who had heard of FOBT, evidence indicated that men and married people 
were more likely to be considering FOBT than women and single people. Results of this 
survey suggested that many people in this Canadian province had not heard of FOBT and 
among those who had heard of it; many were not considering screening. Because of the 
relatively low awareness of FOBT, the sample size and statistical power of the analysis 
on intention to screen were reduced.  
Considerable variability exists across populations with regard to the socio-
demographic and awareness factors that have an impact on screening intention. This 
underscores the importance of treating each population as distinct when attempting to 
determine factors that may or may not influence intention to participate in CRC 
screening. It is clear that no two populations are identical in terms of what drives or 
influences their reported intention to take part in screening. Table 2.2 summarizes each of 
the studies on CRC screening intention that were described previously.  
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Table 2.2 Summary of Articles on Intention to Screen (2000-2012) 
First Author Publication 
Year 
Country Population Results 
Significant Factors N.S. Factors 
1. Duncan, A. 2009 Australia Age 50-74 
Urban 
Men and women 
n = 664 
Method: Mail-out survey 
Response rate: 55% 
Positive intention: 31.1% 
 
Age, Gender – youngest 
and oldeest age groups 
and men  more likely to 
in action phase of 
screening intention 
(univariate analysis) 
Not reported 
2. Weinburg, 
DS. 
2009 U.S.  Age 50+ 
Women 
Average risk and non-compliant with 
screening 
n = 318 
Method: Telephone survey 
Response rate: 49% 
Positive intention: 35% 
Age – older age 
associated with higher 
intention of being 
screened 
 (multivariate analysis) 
Employed 
Married / Partnered 
Level of education 
Knowledge of CRC 
3. Christou, 
A.  
2012 Australia Age 35+ 
Aboriginal or Torres Straight Islanders 
Men and women 
n = 93 
Method: Interview-administered survey 
Response rate: Convenience sample 
Positive intention: 63% 
 
Marital Status (married 
or defacto married), 
Employed  (vs. 
unemployed), 
Education (more highly 
educated), Income  
(higher income), Other 
screening (participated in 
any cancer screening in 
past 2 years), Awareness 
(someone in family with 
CRC, ever heard of a 
CRC screening test) were 
more likely to report an 
intention to participate in 
screening  
(univariate analysis) 
Gender  
Age 
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Age (older age), Other 
screening, Marital 
Status (married) and 
CRC awareness were 
predictors of intent to 
participate in screening 
(multivariate analysis) 
4. Han, MA.  2011 Korea Age 50+ 
Men and women 
n = 955 
Method: Interview-administered survey 
Response Rate: 17.5% 
Positive intention 34.1% 
Age – Intention to screen 
was significantly higher 
in younger adults (50-59 
and 60-69 vs > 70) 
(multivariate analysis) 
Gender 
Education 
Income 
Marital Status 
Residence (town, middle 
& small sized cities, large 
cities) 
Family cancer history 
5. Sifri, R.  2010 U.S.  Age 50-74 
Average risk for CRC 
Primary care patients 
Men and women 
n = 1515 
Method: Telephone survey 
Response rate: 58.7% 
Positive intention: 51% 
Age – Intention to screen 
was significantly higher 
in younger adults (<60 
yrs) 
Other screening  - more 
likely to intend to screen 
if participated in any 
cancer screening  
(multivariate analysis) 
Gender 
Marital Status 
6. Tong, S. 2000 Australia Age 40-80 
Men and women 
n = 884 
Method: Telephone survey 
Response rate: 77.8% 
Positive intention: 77.5% 
Age – Intention to was 
significantly higher in 
younger adults (40-59 
yrs), Marital Status 
(married or de facto 
married), Education 
(more highly educated), 
and Income (higher 
household income) 
(univariate analysis) 
 
Knowledge of a friend or 
relative with CRC 
Number of first degree 
relatives with CRC 
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Age (younger age) and 
Education (more highly 
educated) 
(multivariate analysis) 
7. Tong, S. 2006 Australia Age 40-80 
Men and women 
n = 884 
Method: Telephone survey 
Response rate: 77.8% 
Positive intention: 77.5% 
Awareness of FOBT 
(more likely to express a 
positive intention to 
screen) and Prior use of 
FOBT (more likely to 
express a positive 
intention to screen) 
(univariate analysis) 
Not reported 
8. Janda, M. 2003 Australia Age 50-74 
Men and women 
 n = 604 
Method: Telephone survey 
Response rate: 79.4% 
Positive intention: 53% 
Age (<70 more likely to 
report positive intention), 
Education (more highly 
educated), and 
Awareness (family 
history or knowledge of 
someone with CRC) 
(univariate analysis) 
 
Prior use of FOBT(more 
likely to express a 
positive intention to 
screen), Age (70-74 yrs 
less likely to report 
positive intention, 
Awareness (knowledge 
of someone with CRC) 
(multivariate analysis) 
Gender 
Without or without a 
partner 
9. Gregory, 
TA.  
2011 Australia Age 50-74 
Men and women 
n = 376 
Method: Mail-out survey 
Response rate: 56% 
Positive intention: 7.6% 
Gender (male) 
Past Cancer Screening  
Awareness (knowledge 
of someone with CRC), 
Place of birth 
(Australia), English 
Age 
Marital Status 
Employment Status 
Education Level 
Private Health Insurance 
Socio-economic Status 
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Speaking more likely 
report readiness to screen 
(univariate analysis) 
Other Screening, 
Awareness (higher 
perceived knowledge 
about CRC) 
(multivariate analysis) 
10. Ritvo, P.  2009 Canada Age 50+  
Men and women (Intention or readiness 
analysis focused on those who were 
aware of FOBT) 
n = 1013 
Method: Telephone survey 
Response rate: 69% 
Positive intention 17.1% 
Gender (men more likely 
to report readiness to 
screen), Marital status 
(married people) 
(univariate analysis) 
 
Gender (men more likely 
to report readiness to 
screen), Marital status 
(married people) 
(multivariate analysis) 
 
 
 
 
 
 
59 
 
2.4.4 The Intention – Behaviour Pathway 
Intention has been found to be reliably correlated with many screening behaviours 
including participation in CRC screening94. It would be an oversight within the scope of this 
review, however, to omit acknowledging that it is not solely intention that determines whether an 
individual will carry out a given behaviour. In some instances, predictors of intention can be 
analogous to predictors of actually performing the behaviour, while in other instances this is not 
the case. A previous review found that across a variety of health-related actions, average 
compliance among ‘intenders’ was only 56%95. Follow-up work, beyond the scope of this thesis, 
should be done to determine the strength of the correlation between reported intention and 
screening participation in the NL population.  
 Among the studies of screening intention described in the previous section, only one 
included a follow-up phase that examined whether people went on to participate in FOBT 
screening92. This study found that gender (male), past cancer screening and knowing someone 
with cancer were positively associated with readiness to screen. Only two of these three factors 
were significantly associated with screening participation (past cancer screening and knowing 
someone with CRC).  
 A more cogent illustration of intention-behaviour differences is found in a study by 
Power et al. (2003)96. The sampling frame for this study was all patients aged 55-64 registered 
with 53 general practices in Scotland. All eligible patients were sent a letter and information 
sheet from their general practitioner describing the screening test and inviting them to complete 
an enclosed questionnaire on screening intention. For the analysis, participants were categorized 
by their initial intention and their subsequent attendance at screening creating three groups: 1) 
non-intenders: participants who said they would ‘probably not’ or ‘definitely not’ take up the 
 
 
60 
 
offer of screening (this group was not invited for screening), 2) ‘attenders’: those who responded 
‘yes definitely’ or ‘yes probably’ to the intention question and attended screening, and 3) non-
attenders: those who responded ‘yes definitely’ or ‘yes probably’ to the intention question but 
did not attend screening. In total, 6,383 people responded to the screening intention 
questionnaire. Differences between non-attenders and attenders are of particular interest here as 
predictors that strengthen or weaken the intention-behaviour pathway may be identified through 
these differences. Attenders were more likely to be married or co-habiting, 73.1% vs. 66.7% [χ2 
= 35.17, p < 0.001], and in full time employment, 24.6% vs. 17% [χ2 = 73.89, p < 0.001]. On a 
composite measure of socio-economic deprivation, (components included car ownership, level of 
education and housing tenure), attenders were more likely to be affluent (27.7% vs 16.1%) and 
less likely to be experiencing deprivation (8.9% vs. 18.2%) than non-attenders [χ2 = 124.23, p < 
0.001]. Perceived stress was higher in non-attenders, 9.1 vs. 8.6, [F = 6.59, p < 0.001], while 
social support, 24.1 vs. 23.2, [F = 12.17, p < 0.001], and ratings of health as excellent, 12.6% vs 
7.7% [χ2 = 52.9, p < 0.001], were higher in attenders.  
 A strong association between intention strength and attendance was observed in this 
study, 72% of those who said ‘yes definitely’ attended for screening, compared with 45% of 
those who said ‘yes probably’ [χ2 = 113.15, p < 0.001]. When data were stratified by intention 
strength (‘yes definitely’ and ‘yes probably’), analyses showed that socioeconomic deprivation 
remained an important predictor of action.  Social cognition conceptualizations (associated with 
behavioural theory) successfully distinguished between those who intended to come for 
colorectal screening and those who did not intend to come, but showed less capacity to 
discriminate between those whose intentions were successfully translated into actions and those 
who failed to act.  
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Findings such as those reported in the Power et al.96 study support the approach of this 
thesis. Focusing on the pre-implementation stage of a screening program as one component of 
program evaluation appears to be of value.  Pre-implementation work can identify challenges or 
vulnerable populations prior to program implementation by affording the opportunity to ask 
about intention to participate which has been shown to have predictive value for action or 
behaviour. Furthermore, there is empirical support in the literature for socio-economic, 
demographic and knowledge/awareness factors as predictors of both 
intention84,,85,86,87,88,89,90,91,92,93 and action96,97,98,99,100,101,102.  
2.4.5 Geography 
Geography, specifically urban and rural differences in CRC screening, are considered 
separately. The primary reason for this is that the relationship between geography and CRC 
screening intention is a key feature of this thesis and warrants specific attention. Secondarily, 
geography did not appear to be explored as a predictor of CRC screening intention as per the 
articles reviewed in section 2.4.3. NL is a province made up primarily of rural and remote 
communities. It is important to consider the unique needs and perspectives of those who reside in 
rural areas of NL when conducting research on a program that will be provincial in scope. All 
too often the perspectives and experiences of those who live outside the urban region of St. 
John’s are not incorporated into research, and sometimes the views of the urban dwelling 
population are portrayed as provincial views. Efforts to include rural dwelling individuals were 
consciously and consistently made in this study, not only to elicit a diversity of perspectives on 
intention to screen, but to better understand the role that geography itself may play in shaping 
screening intention. This endeavor is supported by the assertion of the Canadian Health 
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Commission that geography is a determinant of health103. Might geography also be a determinant 
of intention to engage in healthy behaviours such as CRC screening?  
In 2006, the Canadian Institute for Health Information (CIHI) released a pan-Canadian 
report on the health of rural populations104. The report summarized that rural areas generally 
showed a health disadvantage on many health-related measures when compared with urban 
areas; although there were some areas where differences were not pronounced and some adverse 
health measures were found to be higher in urban areas. Rural areas reported higher proportions 
of people with low income and less than secondary education level. These factors have been 
linked with lower screening intention and screening action in several populations. Furthermore, 
the report detailed that health-related factors such as smoking and obesity were more prevalent in 
rural areas, as were poorer dietary practices and lower levels of physical activity. These factors 
have been identified as risk factors for developing many types of cancer.  
Kulig and Williams reiterate these findings in a more recent publication titled Health in 
Rural Canada105. These authors/editors report that rural Canadians experience a greater number 
of population health risks compared with urban Canadians.  Rural Canadians generally have 
lower economic status due to higher unemployment rates and lower education rates than do 
urban Canadians. They also have a shorter life expectancy and higher mortality and infant 
mortality rates than the Canadian average. In addition to socio-demographic contributors, Kulig 
and Williams report that poorer rural health is partially due to the result of shortcomings in 
overall, general health care services. Ongoing challenges in recruiting and retaining health 
professionals in rural geographies mean that rural residents experience many obstacles in 
obtaining care due to lack of available services and personnel. There are also geographical and 
transportation limitations.  
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In the realm of cancer care, NL-specific analyses have been carried out to determine 
whether the degree of rural / remoteness of a geography has an impact on various aspects of the 
cancer care experience. National findings can be found in a pan-Canadian report published by 
CPAC106. Province-specific findings are available in tabular format on the cancerview 
website107. Geographic disparities in NL, with a marked disadvantage for those living in rural / 
remote regions, were found in a number of areas. These included wait time from an abnormal 
breast screen to resolution of that screen (whether or not the resolution required a tissue biopsy to 
be carried out), radiation therapy utilization and the percentage of breast cancer resections that 
were mastectomies.  
The wait time for resolution of an abnormal breast screen increased along the urban / 
rural gradient from 12.9 weeks to 15.9 weeks for those who did not require a tissue biopsy and 
from 19.3 weeks to 22 weeks for those who did require a biopsy. Radiation therapy utilization 
within two years of diagnosis decreased from 32.5% of cancer cases diagnosed in a given year to 
27.8% of cases as geography became more remote. Lastly, the percentage of breast cancer 
resections that were mastectomies increased from 37.5% for urban areas up to 52.3% for rural / 
very remote areas. 
In the literature on geography as an influencer of CRC screening, living in a rural area 
generally appears to be negatively correlated with having participated in screening. Several 
American studies comparing cancer screening between urban and rural dwelling populations 
provide evidence of lower participation rates and lower likelihood of being up to date with CRC 
screening108,109,110,111 in the latter population. 
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There is less literature available in the Canadian context, however, one Canadian-based 
study conducted a data linkage / secondary data analysis study using provincial and national 
administrative databases112. The target population were those aged 50 - 74 and six years of 
cohorts were examined from 2005 – 2011, for a sample of 12, 824, 179. Fourteen percent of this 
sample were living in rural areas. Analyses found that there were significant inequities in FOBT 
participation by geography. Those living in rural areas were consistently less likely to participate 
in FOBT screening, 6.1% versus 7.9% in urban areas, for a difference of -1.8% (95% CI -1.9% - 
-1.7%). Similarly, those living in rural areas were consistently less likely to be up-to-date with 
CRC screening than those living in urban regions, 25.1% versus 27.6%, for a difference of -2.5% 
(95% CI -2.7% - -2.3%).  
Research on outcomes associated with other events along the cancer trajectory has also 
shown a disadvantage for rural dwelling residents with CRC. For example, rurality was 
associated with a later stage at diagnosis113, lower odds of receiving chemotherapy114, increased 
risk of local recurrence of cancer115 and decreased survival time114,115. 
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2.5 Hypothesis and Summary of Study 1: Target Population Survey 
Although literature is available for various aspects of CRC in relation to place of 
residence, including diagnosis, treatment, prognosis, and screening participation, there appears to 
be a paucity of literature on rurality as it is related to reported intention to engage in screening. 
Based on evidence of less desirable health behaviours and outcomes for rural dwelling 
individuals, of particular relevance to this study, their lower likelihood of having participated in 
CRC screening, it is hypothesized that those at average risk for CRC living in rural areas of NL 
will be less likely to report an intention to participate in the FOBT screening program than those 
at average risk living in an urban area. Identification of groups with differing intention may lead 
to opportunities to influence intention and subsequently enhance screening uptake. The 
opportunity will also be taken in this study to extend the scope and impact of the novel data that 
will be collected. This will be done by including two rural populations in data collection. As 
discussed in chapter one, NL has regions with familial clusters of high genetic risk CRC,3,4,5,6 
and there is interest gaining a better understanding of whether the presence of a population such 
as this has any impact on the screening intention of average risk individuals that reside in these 
regions. Knowing that awareness of others with CRC can positively impact the intention to 
participate in screening86,91,92 has led to the question: Does the presence of a familial cluster of 
high genetic risk CRC mediate the potential health disadvantage of living rurally and strengthen 
the likelihood of positive screening intention for those at average risk for CRC? 
In order to answer this question, samples from three distinct areas of the province will be 
surveyed – an urban area with no familial clustering of high risk CRC, a rural area with no 
familial clustering of high risk CRC and a rural area with a familial cluster present. Respondents 
at average risk for CRC from each of these areas will be compared on reported intention to 
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participate in FOBT screening. This is the primary research question of this study. It is 
hypothesized that individuals 50 to 74 years of age, who are at average risk for CRC, and who 
are residing in a rural region with a presence of high genetic risk CRC will have the highest 
proportion of reported positive screening intention; the next highest proportion will be those who 
live in an urban region; and those who live in a rural region without a significant presence of 
high genetic risk CRC will have the lowest reported proportion of positive screening intention. 
Secondary analyses will involve the examination of other socio-demographic characteristics in 
relation to screening intention, comparing each of the geographies and considering the study 
population as a whole.  
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2.6 Primary Care and CRC Screening 
The method of entry into the NLCCSP will be through participant self-referral or 
physician referral. Access to provincial, population-wide databases, such as the MCP database, 
would present the best available method to equitably reach all members of the target population 
with an invitation to screen. Unfortunately, access to these databases is restricted due to 
provincial privacy legislation. In order to enhance screening uptake as the program is phased in 
across the province, various communication and awareness-raising efforts are planned. These 
efforts focus mainly on the target population for screening and on family physicians. It is quite 
possible that potential participants may consult with their family physician about whether or not 
the screening program is right for them. It is also likely that some family physicians may refer 
patients to the program; if those physicians are aware of the program and endorse it. There is 
considerable evidence to support the positive association between family physician knowledge 
and support of FOBT and patient participation in screening22,23,24,25. Thus, a second part of pre-
implementation work will be to gather information from family physicians across the province 
on their current screening practices, knowledge of FOBT and support for an organized screening 
program.  
2.6.1 Eliciting the Family Physician Perspective 
Several studies exist that endeavor to elicit the physician perspective on CRC screening, 
personal screening preferences, and / or screening practices. The findings illustrate a variety of 
attitudes toward FOBT screening and a range of responses about the use of FOBT in clinical 
practice in several physician populations. Methodological components of two of these studies 
will form the basis for eliciting the family physician perspective on CRC screening in NL.  
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Young et al. (1998)116 surveyed a national random sample of Australian general 
practitioners about the effectiveness of several cancer screening tests including breast self-
examination, clinical breast examination, mammography, annual chest radiology, clinical skin 
examination, FOBT, flexible sigmoidoscopy, digital rectal exam, and the PSA assay. For each 
screening test, respondents were asked to indicate if it was effective in reducing premature 
mortality from the specific cancer site. Belief in mammography outranked the other tests, which 
was consistent with compelling evidence of mammography effectiveness from seven RCTs that 
were available at the time that the survey was carried out. However, despite the effectiveness of 
FOBT in reducing mortality also being demonstrated in RCTs, belief in the effectiveness of this 
test was outranked by seven other screening tests. With respect to CRC screening methods 
specifically, physicians were more likely to believe in flexible sigmoidoscopy despite weaker 
available evidence. Given that belief in the effectiveness of a test will influence whether or not it 
is actually used in practice, it would seem that FOBT would not be readily used by the physician 
population surveyed.  
Another Australian study explored general practitioners’ knowledge, attitudes and 
practices with respect to CRC screening in order to determine GP support for population-based 
screening117. Only half of physician respondents reported that they would support a population 
based screening program utilizing FOBT for persons over 50 years of age. Approximately 15% 
said they would not support such a program and 34% were unsure. Various reasons were given 
by supportive physicians including; FOBT is non-invasive, CRC incidence is high, FOBT is 
simple and quick to use, population-based FOBT reduces mortality rates and FOBT is less 
expensive than other screening options. Reasons given for not supporting a population-based 
screening program included the perception that FOBT yields a high proportion of false positives 
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and false negatives, FOBT is not cost-effective, and patients are unwilling to comply with 
FOBT. The majority of respondents (84.3%) thought it was important that GPs be involved in 
any future screening programs and two-thirds (64.4%) were unsure or disagreed with the 
statement that populations screened with FOBT have lower mortality from CRC than those who 
have not been screened. A similar percentage (64.7%) reported always or often asking patients 
over 50 years old about symptoms or risk factors for CRC, 80% reported that they have used 
FOBT for their patients, and 50% that they were not confident in instructing patients about 
FOBT. Close to three-quarters reported a desire for more education  and training about CRC 
screening.  
The underlying message from this study is that there appears to be a great deal of 
uncertainty amongst the physician population about the effectiveness of FOBT as a screening 
test and about the benefit of FOBT screening on a population level. Overwhelming support for 
population-based screening with FOBT was not apparent, with only 50% of physicians 
indicating their support. It is, therefore, not surprising that a high percentage of physicians were 
unsure of, or disagreed that, screening populations using FOBT resulted in a reduction in 
mortality from CRC. Lack of familiarity with the test seems to be significant, with half of 
physicians reporting that they were not confident in instructing patients on how to use FOBT. It 
is encouraging, however, that there was a high level of interest in receiving further education and 
training about screening.  
Taking a somewhat different perspective, an Ontario study surveyed family physicians 
about their personal choices of CRC screening modalities, as well as about their perception of the 
preferred screening choices of their patients118.  Decennial colonoscopy and biennial FOBT were 
the two most popular screening methods, accounting for more than 90% of both the physicians’ 
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personal preferences and their perceptions of patient preferences. Interestingly, personal 
preferences and perceived patient preferences differed. Sixty-four percent of physicians thought 
their average-risk patients would prefer FOBT screening and only 29% thought their patients 
would prefer colonoscopy. In contrast, 40% of family physicians would want FOBT for 
themselves with 50% preferring colonoscopy. The difference in physicians’ personal screening 
choices and their perceptions of patients’ preferences was statistically significant [χ2 = 150.5, p < 
0.001]. It is not clear why physicians would choose one test for themselves but perceive another 
to be more desirable to their patients. While causality for these preferences could not be 
determined from this study design, personal screening choice of physician was significantly 
associated with physician-estimated FOBT sensitivity [χ2 = 14.75, p  < 0.005], perception of 
mortality reduction [χ2 = 113.3, p < 0.001] and cost-effectiveness [χ2 = 87.12, p < 0.001].  
Screening practices, as opposed to preferences, were examined in another Canadian 
setting (Calgary) in a survey of family physicians, gastroenterologists, general and colorectal 
surgeons and general internal medicine specialists119. Physicians were asked whether they had a 
screening policy for asymptomatic individuals with and without a family history of CRC. Those 
patients without a family history would correspond to an average risk population, while those 
with a family history would represent higher risk. Approximately 60% of respondents reported 
having a screening policy for asymptomatic individuals without a family history of CRC, while 
the remaining proportion had no policy for this subgroup. Of those who reported having a 
screening policy for family history negative patients, 63.6% initiated screening at 50 years of age 
and FOBT was the most commonly used screening test either alone or in combination with other 
modalities. For patients with a family history of CRC, almost all physicians (96.4%) reported 
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that they employed a screening policy. Colonoscopy was the most common screening modality 
chosen.  
It would appear in this physician population that having a screening policy in place is a 
much higher priority for patients with a family history of CRC. While it is reassuring that a 
policy was almost universally in place for this group, screening of the average risk population 
appeared to be less structured. This was particularly so amongst family physicians and internal 
medicine specialists of which 59% and 38% respectively reported having a screening policy for 
asymptomatic patients with no family history. Primary care would likely be the portal through 
which asymptomatic average risk patients would enter a screening pathway and it is concerning 
that almost 40% of family physicians did not have a tangible approach or policy to starting 
people on this pathway. 
The final study elaborated on is a comprehensive, province-wide, cancer screening needs 
assessment carried out in British Colombia (BC) which contained a considerable amount of data 
on the primary care physician (terminology used in the assessment) perspective of cancer 
screening in that province120. Although screening modalities for several cancer sites were 
included in the assessment, the CRC screening components of the survey will mainly be 
discussed. The survey covered knowledge and attitudes towards cancer screening, attitudes 
towards educational approaches aimed at increasing the overall prevalence of cancer screening, 
barriers towards engaging in cancer screening discussions with well patients, and self-reported 
practices on screening for cancer. Demographic information and practice characteristics were 
also collected.  
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The majority of primary care physicians (94%) felt that screening for cancer in well 
patients was advantageous, and 85% felt that they effectively communicated screening strategies 
to their patients. Slightly fewer (79%) felt that their patients followed their recommendations for 
cancer screening. Sixty-three per cent reported that their patients either ‘never’ or ‘seldom’ 
requested FOBT and 6% reported that their patients either ‘often’ or ‘always’ asked for FOBT. 
The remaining 31% chose the ‘sometimes’ category. The breakdown was different for 
colonoscopy where only 28% of physicians reported that their patient never or seldom requested 
colonoscopy, 20% reported that their patients often or always requested colonoscopy and 51% 
chose sometimes. This illustrates that in the primary care physician experience in BC, patients 
infrequently request FOBT.  
Only 34% of physicians reported having CRC screening educational materials available 
for patients. Most physicians preferred conferences as the educational format for learning about 
cancer screening (73%) and their preferred sources of accessing cancer screening guidelines 
were web-based resources (58%) and paper-based resources (49%). 
Several barriers were identified in relation to discussing cancer screening with patients 
including having to deal with other co-morbidities in a clinical consult, the time it takes to 
explain the pros and cons of cancer screening options, physician financial compensation, patients 
with language barriers, level of comfort with knowledge to help patients decide on cancer 
screening options, and ability to address patient’s fear about the screening procedure (e.g. 
radiation exposure, pain, embarrassment).  
In addition to screening attitudes and knowledge, physician screening practices were also 
investigated in this needs assessment. The majority of physicians reported starting to recommend 
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CRC screening in their well patients in the 50-54 age range, which is consistent with Canadian 
CRC screening guidelines. However, the most frequent response given for patient age range at 
which the physician stopped recommending screening was ‘I don’t stop recommending CRC 
screening’ (40%), followed by 80-84 age range (23%). Neither one of these responses are 
consistent with screening guidelines for the recommended stop age of 74 years. The procedures 
most commonly recommended were colonoscopy (87%), digital rectal exam with FOBT (82%) 
and FOBT completed at home (82%), (numbers do not sum to 100% because respondents could 
choose more than one response). 
This needs assessment provides a useful summary of BC primary care physicians’ 
knowledge, attitudes and behaviours about CRC screening. It would appear that physicians think 
that cancer screening is advantageous and feel that they effectively communicate cancer 
screening information to their patients.  Overall, patient awareness of FOBT, or possibility 
patient belief in the effectiveness of FOBT does not seem to be high with a reported 6% of 
patients ‘often’ or ‘always’ asking about FOBT. With respect to the patient population, 
physicians were asked to answer these questions in the context of thinking about their ‘well’ 
patients. The study therefore, did not make any distinction between physicians’ attitudes and 
screening practices for their average risk versus high risk patients. Additionally, several of the 
questions referred to cancer screening in general, as opposed to CRC screening specifically. 
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2.7 Summary of Study Two 
Eliciting NL family physicians’ knowledge, attitudes and practices around CRC 
screening will be the second major component of this thesis. Elements of the BC needs 
assessment survey will be utilized to collect this information; however, some adaptations will be 
made to the survey before it is used in NL. Adaptations will focus on extracting the CRC 
screening questions and re-wording the general screening questions to have a CRC screening-
specific focus.  Permission has been granted from the relevant sources at the BC Cancer Agency 
to do so (email correspondence with co-investigator Ms. Laura Swaré, Februray 7th, 2012, 
Appendix A). 
While the BC Cancer Agency Needs Assessment instrument does address many areas 
relevant to this thesis, there is no content on attitudes toward FOBT screening on a population 
basis or physician belief in the effectiveness of FOBT as a viable screening modality. These will 
be important areas to address in the context of doing a pre-implementation assessment of 
physician support for the program. Therefore, the measure used by Tong et al. (2004)117, as 
described previously, will also be administered to physicians. Further information and detail on 
survey content and methodology will be provided in chapter four.  
It is hoped that the two major components of this PhD thesis, an average risk population 
survey and a family physician survey will yield valuable data which will inform and support 
more efficacious implementation of the CRC screening program in NL. Little is currently known 
about rural residents’ screening intentions compared with their urban counterparts. Moreover, it 
is not known whether the presence of a high genetic risk for CRC population might have an 
impact on CRC awareness and intention to participate in preventive behavior for those who are 
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at average risk for the disease. Similarly, little is known about family physicians’ attitudes 
toward FOBT screening or about their screening practices in this province. The concept of an 
organized CRC screening program is still in its infancy in NL and the pre-implementation phase 
provides an opportunity to proactively facilitate the best possible operation of this program. This 
research is supported by a framework central to the field of epidemiology called the 
Measurement Iterative Loop121.  
 
Figure 2.1 The Measurement Iterative Loop (CC-BY-NC-SA 3.0) 
Source: http://www.jcd.org.in/viewimage.asp?img=JConservDent_2012_15_1_5_92598_u3.jpg 
 
The main aim of implementing a screening program is to reduce the burden of disease in 
a population. FOBT screening has been shown to reduce incidence of and mortality from CRC. 
Screening can also detect disease at an earlier stage, possibly leading to less invasive treatment 
requirements and enhanced quality of life. Thinking of screening program implementation as an 
iterative process provides a useful framework for how this work can be carried out in a 
standardized and rigorous manner. An understanding of the burden and aetiology of the disease, 
along with evidence to support the effectiveness and efficiency of an intervention are integral 
parts of implementation. Monitoring progress and re-assessing practices provide a means to 
recalibrate and improve processes where necessary. Conducting pre-implementation work to 
better understand the target population and the broader primary care context fits with this model 
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of health intervention implementation and will hopefully lead to better outcomes for those which 
the program is meant to serve.  
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Chapter Three 
Study Summary 
3.1 Target Population Survey  
3.1.1 Problem Statement 
NL has the highest ASIR and ASMR of CRC in Canada. Screening using FOBT has been 
shown to reduce mortality and lower disease incidence. In order for screening to have an impact 
on the burden of disease, sufficient uptake of screening must occur. NL is in the early stages of 
implementing an FOBT screening program for those at average risk for CRC. This pre-
implementation stage of screening may provide an opportunity to better understand the NL 
average risk population’s intention to engage in screening, and to intervene if potential 
challenges are detected. 
3.1.2 Study Purpose and Hypothesis 
The primary objective of the study is to compare intention to participate in CRC 
screening amongst three distinct geographic regions. Exploring screening intention by geography 
may yield new information on how various geographical features including rurality and presence 
of high risk populations may impact or mediate intention to screen. Secondary objectives of the 
target population survey are to determine the overall target populations’ intention to participate 
in an FOBT screening program and to explore various socio-demographic variables that may be 
associated with intention to screen.  
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 It is hypothesized that individuals at average risk for CRC living in a rural area with the 
presence of a familial cluster of high genetic risk CRC will be proportionally more likely to 
report positive screening intention than those living in an urban area without a familial cluster of 
high genetic risk CRC. Following from this, it is also hypothesized that those living in the urban 
area will be proportionally more likely to report positive screening intention that those living a 
rural area, without a familial cluster of high genetic risk CRC.  
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3.2 Family Physician Survey  
3.2.1 Problem Statement  
Little is currently known about NL family physicians’ attitudes toward FOBT screening 
or about their practice patterns with respect to CRC screening of the average risk population. 
Better established is that the use of endoscopy surpasses use of FOBT in this province. There is 
evidence that highlights the positive role that family physicians can play in endorsing CRC 
screening uptake. Furthermore, it is known that family physicians are more likely to recommend 
a test if they believe in its efficacy. Therefore, it is beneficial to better understand the knowledge 
of and attitudes toward FOBT screening, and the average risk screening practices of the family 
physician population in NL prior to full implementation of a CRC screening program.  
 
3.2.2 Study Purpose and Hypothesis 
 The primary purpose of the family physician survey is to determine family physician 
support for a population-based FOBT screening program in NL, to assess knowledge about and 
attitudes towards CRC screening, and to gather information on current CRC screening practices 
in primary care. It is hypothesized that the majority of family physicians will express support for 
an organized CRC screening program for the average risk population, but reported screening 
practices will not adhere current to screening guidelines.  
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Chapter Four 
Methods 
 
4.1 Average Risk Population Telephone Survey 
 
 
4.1.1 Study Population 
This survey targeted individuals at average risk for developing CRC aged 50 to 74. 
Eligibility criteria for average risk included no prior history of colorectal cancer or polyps; no 
presence of inflammatory bowel disease such as Crohn’s disease or ulcerative colitis; and no first 
degree relatives (mother, father, child, brother or sister) diagnosed with CRC before age 60.  
Based on the intent of the study, and more broadly, the intent of the average risk CRC 
screening program in NL, the lack of precise documentation about familial history of the 
screenees was not viewed as problematic. Participation in the screening program can be initiated 
either by participant self-referral or family physician referral. Either way, contact is ultimately 
made with the interested individual and a review of the average risk eligibility criteria, as 
described previously, is conducted. This is done by a clerical person and the intent is neither to 
thoroughly verify all family history of CRC, nor to document a familial pedigree. Eligibility 
criteria are in place to attempt to stratify individuals according the screening strategy that is 
optimal for their level of risk. However, there is no mechanism to ensure that what is reported is 
entirely accurate.  For a population-wide program, it would not be feasible to conduct such an 
intensive validation process with each screenee. In the real-world screening program, the 
eligibility criteria are reviewed and if the person reports fitting the eligibility criteria, they are 
sent a screening kit, regardless of whether they may have an unknown family history or may be 
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incorrect about their family history. This approach was also followed for the thesis work, i.e., if a 
person fit the eligibility criteria of average risk and completed a survey, their result was included.  
The desire was to mirror, as much as possible, operation of the screening program. Thus, it is 
entirely possible that people who have an unknown or incorrect perception about their family 
history for CRC will be included in the average risk screening program and were included in the 
target population survey. This possibility exists for all regions sampled and is not regarded as a 
bias because if a person is unaware of an increased risk for CRC, they are likely to respond to 
questions and approach screening activity with the mindset of an average risk person. The intent 
of the survey was to better understand whether the presence of high risk families in an area 
would impact the screening intent of those at average risk. A person who considers themselves to 
be at average risk according to the best of their knowledge about their family history is 
considered an eligible person for the study and for screening. Although no literature is available 
comparing urban and rural populations on accuracy of reporting familial incidence of CRC, a 
population-based study reported a positive predictive value (PPV) of 53.5% [95% CI = 33.0 -  
72.8] and a negative predictive value (NPV) of 98.1% [95% CI = 96.6 – 98.9] on reports of 
family incidence CRC by study participants compared to a reference standard122. Furthermore, 
reports on first degree relatives had a significantly higher PPV, and thus greater accuracy, than 
reports on second degree relatives [85.8% versus 43.5%, p = 0.04]. A second study found a PPV 
of 79.8% [95% CI = 73.9 – 84.9], a NPV of 98.6% [95% CI = 97.9 – 99.2] and a probability of 
agreement of having CRC between the reporting individual and a reference standard of 89.7%123. 
The false negative rate for CRC was 10.3% for first degree relatives, followed by 42.4% for 
second degree relatives and 63.6% for third degree relatives. Thus, although some 
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misclassification is possible, it would appear that individuals are able to reliably report on the 
family history of CRC for their first degree relatives.  
Three distinct geographies or regions in Newfoundland were selected: one urban without the 
presence of a familial cluster of high genetic risk CRC, one rural with the presence of a familial 
cluster of high genetic risk CRC  and one rural without the presence of a familial cluster of high 
genetic risk CRC. The three regions initially targeted were: St. John’s, capital city of the 
province and home to major tertiary health care centres (ARU); the New-Wes-Valley Region 
(Badger’s Quay, Pool’s Island, Brookfield, Wesleyville, Pound Cove, Newtown, Valleyfield and 
Templeman), Lumsden and Greenspond (HRR). This region is approximately 375km from St. 
John’s. The closest major centre is Gander which is 75km to the west of the New-Wes-Valley 
region and has a population of roughly 10,000; and Burin and surrounding communities (Fox 
Cove – Mortier, Port au Bras, Salmonier), Marystown and surrounding communities (Jean de 
Baie, Rock Harbour, Spanish Room) and Grand Bank (ARR). The Burin region is 320 km from 
St. John’s. The largest centre in the Burin region is Marystown with a population of roughly 
5,400 people. 
The region with a presence of high risk hereditary CRC was chosen under advisement 
from Dr. Jane Green, Memorial University, a leading researcher in the area of high risk CRC. 
The “Family C” cluster of 15 large HNPCC or Lynch Syndrome families with a known mutation 
is originally from Swain’s Island of Wesleyville. Many members of this family cluster live in 
communities in New-Wes-Valley region along with Lumsden and Greenspond (Appendix B 
email correspondence from Dr. Jane Green January 22, 2012 and February 20, 2012).This 
decision was corroborated by others with expertise in this area, including the supervisory 
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committee members. Figure 4.1 shows a map of the province depicting the various regions 
targeted.  
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Figure 4.1. Regions of the Province Targeted for Average Risk Population Survey  
 
 
 
 
85 
 
According to Community Accounts124, which makes use of census data to provide 
population counts for various levels of geography in NL, the population of those aged 50-74 in 
St. John’s or the ARU region is 26,835. In the HRR it is 1,245, and in the ARR, it is 2,890. 
4.1.2 Study Methods   
Phone numbers for the relevant communities were purchased from InfoCanada. 
InfoCanada is a company that houses databases of contact information based on the latest census 
data. The phone numbers provided to purchasers are randomly selected from the available 
universe of all numbers that fit the desired criteria. Telephone surveying has a number of 
advantages over face-to-face interviewing allowing greater ease of access to geographically 
remote areas and lower costs. Furthermore, because of anonymity, telephone surveys may be 
useful in collecting data of a sensitive nature125. Limitations of this methodology include lack of 
representativeness because households with no landline are not represented. In an age where 
cellular phone ownership is commonplace, this may be an increasing possibility. However, 
telephone survey is frequently used and was found to be an effective recruitment strategy in 
other surveys on screening as reviewed Chapter Two of the thesis85,88,89,90,91,93. Telephone survey 
was utilized in six of the ten screening intention surveys reviewed and response rates ranged 
from 49% to 79.4%. Additionally, a case-control study conducted in NL employed random digit 
dialing as the recruitment method and achieved a response rate of 45.1%126. Although this 
response rate is at the lower end in comparison with the response rate of the studies reviewed, 
telephone surveys, in general, achieve a higher response rate than self-completion and mail-back 
surveys127,128 and, as such, this methodology was chosen for this study.  
 
 
86 
 
Trained staff members of the Primary Research Healthcare Unit of the Discipline of 
Family Medicine, Memorial University of NL were contracted to carry out the calls. Training 
was provided to ensure that standardized methodology was utilized when conducting the 
telephone surveys.  When contact was made with the resident of a household, a telephone script 
that was incorporated into the average risk population survey (Appendix C) was followed to 
determine whether the person on the line was interested in taking part in the study and if they 
were not interested, whether there was anyone else in the household who was within the 
appropriate age range who might be interested. If no one in the household was interested and/or 
of the appropriate age range, the person on the line was thanked for their time and the call was 
ended. If there was someone in the household who was within the appropriate age range and 
interested in taking part in the study, further questions were asked to determine eligibility with 
respect to risk level for developing CRC. If the respondent fit the criteria for eligibility, the 
interviewer proceeded with the survey. Participants were told that participation was voluntary, 
that they could refuse to answer any questions, that they could stop the survey at any time, and 
that their responses would be kept confidential.  
4.1.3 Modification to Average Risk Population Survey Methodology 
 Early in the administration of the telephone survey it became apparent that telephone calls 
were not going to be an efficacious modality to yield the required sample size. The telephone 
survey was initiated in January 2013 and after logging 52 hours of calling, only 41 surveys were 
successfully completed. A detailed account of the telephone survey process is as follows: 869 
unique numbers were called; 41 completed the survey; 115 were not in service; 100 declined to 
participate; 208 did not meet the eligibility criteria; 404 did not answer and 1 refused to continue. 
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Based on these results, a decision was made to change the survey administration modality 
to a mail-out strategy.  An amendment form requesting this change was submitted to the Health 
Research Ethics Board and was approved (Appendix D). An information letter was drafted 
(Appendix E) and the survey was formatted for mail-out (Appendix F). 
Round one of the mail-out survey used address contact information from the same 
database purchased from InfoCanada for the telephone survey. This mail-out was impacted by 
the poor quality of the information provided. Addresses were only included for a portion of the 
numbers listed in the database and many of those addresses were incorrect. The response rate 
was still low after the first mail-out attempt, particularly in the rural areas. A decision was made 
to switch to Canada Post’s unaddressed admail method to distribute the surveys to the selected 
communities.  
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4.1.4 Sample Size and Analysis Plan 
In estimating the sample size for the average risk population survey, the parameters were 
set of no more than a 5% margin of error and a confidence level of at least 95%. The sample size 
calculation was driven by the percentage of proposed respondents who would report an intention 
to participate in the FOBT screening program. Fifty per cent was chosen as the assumed response 
distribution for this outcome as this would give the largest required sample size. If the response 
distribution was greater than 50% or less than 50%, the sample size would still be large enough 
to ensure representativeness of the populations from which sampling was taking place. Using the 
known population estimates outlined in the above section, a sample size was calculated for each 
of the three study sites. In St. John’s, or the ARU region, the sample size required was 379; in 
New-WesValley / Lumsden / Greenspond, or the HRR region, it was 294 and in Burin / 
Marystown / Grandbank, or the ARR region, it was 340. This equals a total sample size of 1013.  
With respect to analysis comparing each of the three geographies on the proportion of 
respondents that report intending to participate in the screening program, it was hypothesized 
that the HRR region would have the highest proportion of people reporting ‘yes’ they are 
intending to participate in an FOBT screening program, followed by the next highest proportion 
in the ARU region, and the lowest proportion of people reporting that they intend to participate 
in screening being found in the ARR region. It was predicted that 60% of people in the HRR 
region would say they intended to engage in screening compared with 45% in ARU region. A 
sample size of 173 was required at each site to test this prediction. It was then predicted that 
those in the ARR area would be 15% less likely to participate than those in St. John’s, in other 
words, that 30% would report an intention to participate. This comparison required a sample size 
of 163 for each group. Thus, assuming a required sample size of 173 at each site, the total 
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required sample size would be 519. Due to the larger sample size required to ensure 
representativeness of the populations under study, there will be a sufficiently large sample to 
conduct the comparative analysis.  
Beyond comparing the three regions of interest, analysis focused on determining 
predictors of intention to engage in screening for the total population. This was done by first 
carrying out bivariate chi square analysis to ascertain which predictors were significantly 
associated with reported intention to screen. Those that were significant at the p = 0.1 level in the 
chi square analysis were retained for inclusion in multivariate analysis. Multivariate analysis was 
done using binomial logistic regression.  
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4.2 Family Physician Survey 
 
4.2.1 Study Population 
  All family physicians in Newfoundland and Labrador. The sampling frame was 
developed from two sources: the database of the Office of Continuing Medical Education at the 
Faculty of Medicine and the database of the NL College of Physicians and Surgeons. Although, 
nurse practitioners (NPs) often play a key role in primary care delivery, there are very few NPs 
practicing in a primary care role in NL. For confidentiality reasons, this small number of 
individuals was not targeted in the study as their survey responses would not have been 
reportable as a distinct group.  
4.2.2 Study Methods   
A questionnaire (Appendix G) was developed based on two existing measures. The first 
source was a comprehensive, province-wide, cancer screening needs assessment that was carried 
out by the BC Cancer Agency and which provided a great deal of useful data on the primary care 
physician perspective of cancer screening in that province120. Although screening modalities for 
several cancer sites were included in the assessment, only select CRC screening components of 
the survey were included for this study. Permission was granted from the BC Cancer Agency to 
do so.  
While the BC Cancer Agency Needs Assessment instrument did address many relevant 
areas for this study, it did not include content on attitudes toward FOBT screening on a 
population level or physician belief in the effectiveness of FOBT as a viable screening modality. 
These issues were important areas to address in the context of doing a pre-implementation 
assessment of physician support for the program. Therefore, items adapted from a measure used 
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by Tong et al. (2004)117 were also administered to physicians. Questions focused on whether or 
not the physician would support a population-based screening program utilizing FOBT for 
persons aged ≥ 50 years; reasons for support or lack of support; and whether or not it was 
important for physicians to support screening programs. This measure was not administered in its 
entirety due to repetition of some questions that were already included on the BC Cancer Agency 
assessment.  
The physician survey was administered on a mail-out basis and the Dillman Method129 
was used to enhance response rate. The Dillman method recommends second and third mail-outs 
to survey non-responders. Three weeks after the first mailing, all non-responders were sent a 
second questionnaire; 8 weeks after the first mailing a third questionnaire was sent to the 
remaining non-responders.  In order to ensure anonymity and track responses, a post card was 
sent each time a questionnaire was sent that could be returned separately from the completed 
questionnaire. This provided a way to record who had responded without being able to identify 
individuals from their questionnaire results. An information letter describing the study was also 
included with each survey package, in each round (Appendix H).  
4.2.3 Sample Size and Analysis Plan 
The proposed sample for this survey was family physicians currently practicing in NL. 
Descriptive analysis was carried out for all questions in the survey. The percentage of 
respondents choosing each response category was provided, and where appropriate, the mean 
response was also calculated. According to the BC Cancer Agency analysis plan for the 
physician survey120, for the Likert scale responses (scale 1 to 6), weighted means instead of 
arithmetic means were reported. The weighted mean is calculated by summing the products for 
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each step on the rating scale and the number of respondents choosing the scale (Rating Scale x 
Response Count) and dividing this by the total number of respondents. This procedure was 
followed for the NL analysis. Descriptive analysis was done to provide an overview of the 
sample characteristics and to set the context in which further bivariate and multivariate analyses 
were conducted.  
The primary question of interest was question 11: “Would you support a population-
based fecal occult blood test screening program for all eligible persons in the province over 50 
years of age?” Analysis were planned to determine which variables were significantly associated 
with physician support for population-based FOBT screening and which might play a predictive 
role in determining support. Select questions from the survey were highlighted for this analysis 
including attitude, knowledge and current practice variables, along with certain demographic 
variables. All analyses were conducted using the PASW Statistical Package Version 18. 
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4.3 Ethical Approval and Funding 
Full ethical approval for this study was granted by the Health Research Ethics Authority on July 
23, 2012 (Appendix I). Funding in the amount of $27,000 was awarded by the Department of 
Health, Provincial Government of Newfoundland through the Provincial Cancer Prevention and 
Awareness Grant program.  
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Chapter Five 
Results: Average Risk population Survey 
5.1 Sample 
 As outlined in chapter four, telephone contact was the initial methodology proposed for 
the average risk population survey. This did not prove to be an effective method of recruitment. 
The decision was made to transition to a mail-out survey, and although this method also had 
challenges at the outset, ultimately it resulted in an acceptable response rate. A detailed 
description of the recruitment pathway follows: 
5.1.1 Telephone Survey 
A total of 869 unique numbers were called. Of these, 38 completed the survey (10 
average risk urban, 26 average risk rural, 2 high risk rural); 115 numbers were not in service; 100 
individuals declined to participate; 208 did not meet eligibility criteria; 404 did not answer and 1 
refused to continue. Based on these results, the methodology was changed, and the average risk 
survey was conducted using a mail-out strategy. 
5.1.2 Round One Mail-Out Survey 
For the first round mail-out, the address information utilized came from the same 
database that had been purchased to complete the telephone survey. This information was of 
poor quality.  Addresses were included in the database for only a portion of the phone numbers 
listed and many of the addresses provided were incorrect.  
In the ARU area, 658 survey packages were mailed out. Ninety completed, eligible 
(according to the target population inclusion criteria) surveys were returned, 42 ineligible 
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surveys were returned and 62 packages were returned to sender due to an incorrect address. This 
represented a response rate of 22.8% for all returned surveys and a response rate of 15.1% for 
eligible surveys, out of a denominator of 596 after the ‘return to sender’ survey packages were 
discounted.  
In the ARR area, 321 packages were mailed. No surveys were completed and returned, 
either eligible or ineligible, for a 0% response rate. This was because all 321 packages were 
returned to sender due to an incorrect address.  
In the HRR area, 175 survey packages were mailed, 28 completed eligible surveys were 
returned and 16 completed ineligible surveys were returned. Seven packages were returned 
unopened due to incorrect address.  This yielded a response rate of 26.1% for all surveys 
returned and response rate of 16% for eligible surveys returned, out of a corrected denominator 
of 168.  
While the response rate remained low using this method, it was a much less time and 
labour intensive process compared with the telephone survey method. The decision was made to 
continue using a mail-out strategy, however, survey distribution was switched to Canada Post’s 
unaddressed admail method to mail the surveys to the selected communities. This was done to 
increase the accuracy of the addresses. This method had the added advantage of greatly reduced 
postage rates. 
5.1.3 Round Two Mail-Out Survey 
The response rate for returned eligible surveys in the round one mail-out was used to 
determine the approximate number of packages that would need to be sent to each study area in 
the second round to achieve the desired sample size. Because there was no reference response 
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rate for the ARR area based on round one, the ARU response rate was used. It was lower than 
the HRR response rate and, therefore, felt to be the more cautious estimate. 
 For the ARU area, based on a prior response rate of 15%, 1927 packages were required to 
meet the remaining desired sample size of 289. In total, 2586 packages were sent using the 
unaddressed admail method. The overage was due to the number of households located on mail 
routes. Using Canada Post’s method, it was compulsory to send enough packages for each 
household on the selected mail routes. In total, 395 packages were completed and returned for a 
response rate of 15.3%. Eligible surveys constituted a response rate of 10.3%.  
Using the same expected response rate of 15% for the ARR sample, 2267 packages were 
required to achieve a desired sample size of 340. As with the urban sample, there was an overage 
on packages sent due to the requirement of the admail method to deliver packages to all 
households on all selected routes. In total, 2794 packages were mailed out. Twelve percent of the 
surveys sent out to the ARR population were returned, of these, 6.3% were eligible for inclusion 
in the analysis.  
           A response rate of 17% was assumed for the HRR population based on the round one 
mail-out. The remaining sample size to achieve for this group was 266. The number of mailed 
packages required, based on a 17% response rate, was 1565. In this area, the number of packages 
required to achieve the necessary sample size was greater than the number of possible 
households in this area. Thus, 1209 packages were mailed out in this area using the unaddressed 
admail method. In other words, a package was sent to every possible household. The total 
response rate combining eligible and ineligible packages was 16%. The number of eligible 
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packages returned was 112 (9.3%). Table 5.1 depicts the attained sample versus the required 
sample for each region at the end of the aborted telephone survey and two rounds of mail-outs.  
Table 5.1 Attained Sample Size versus Required Sample Size by Region 
 Average Risk Urban Average Risk Rural High Risk Rural 
Survey Sample Size 
Required 
379 340 294 
Number of Useable 
Completed Surveys 
366 
10 by telephone 
356 by mail 
 
201  
26 by telephone 
175 by mail 
142 
2 by telephone 
140 by mail 
Number 
Outstanding 
13 139 152 
 
 
 After the round two mail-out was completed, it was found that the required sample sizes 
had not been realized for any of the targeted areas. Because study funds were still available, it 
was decided that a third and final round of mail-outs would be attempted for each type of area. 
Given the small population sizes of the two rural regions, it was thought that saturation had been 
reached in each of these areas due to the high volume of packages that had been sent out. It was 
not considered an effective use of remaining resources to resend packages to each of these two 
regions, possibly duplicating households with a probable low return rate. Rather, it was 
determined that new areas should be approached that fit the criteria for the ARR and HRR 
populations.   
 Additional rural communities without the presence of a cluster of high genetic risk CRC 
were identified for the round three mail-out survey. These communities are located on the 
Connaigre Peninsula / South Coast of the province and include McCallum, Milltown, Head of 
Bay d’Espoir, Morrisville, Conne River, St. Alban’s, St. Joseph’s-St. Veronica’s, Harbour 
Brenton, Belleoram, Pool’s Cove, Rencontre East, St. Jacque’s, Coomb’s Cove, Hermitage, 
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Sandyville, Seal Cove, Gaultois, Burgeo, Francois, Grey River, La Poile, and Ramea. This 
constellation of small communities is located approximately 600km from St. John’s. According 
to Community Accounts these communities totaled about 10,640 people. Assuming four people 
per household, this constituted approximately 2600 households to sample from. An additional 
139 responses were required to achieve the necessary sample size of 340. Additionally, to ensure 
less wastage of research resources and unreturned surveys, a $10 incentive was offered to each 
person who returned a completed survey. Doing this required a slight variation in methodology 
from the original mail-out design. In order to receive the $10 incentive, respondents first had to 
return the survey. A postcard on which the respondent could provide their mailing address was 
also included in the package. This card was placed in a separate envelope, which was inserted 
into the survey package. A different person was responsible for opening the envelopes that 
contained the respondent address than the person who compiled the surveys and entered the data. 
By doing this, the respondent address could be retained for remuneration without being able to 
associate the respondent with their survey responses. This was done to maintain confidentiality.  
When a survey was returned, a cheque in the amount of $10 was sent to each respondent, 
whether or not their survey was eligible for inclusion in the sample. An amendment form 
detailing these proposed changes was submitted to the ethics board and approved (Appendix J) 
The cover letter included with the survey packages was also amended to provide instructions to 
respondents, and to detail how their contact information would be kept confidential and separate 
from their survey responses (Appendix K).  
 With respect to sampling further regions with a presence of high genetic risk for CRC, it 
was determined through consultation with Dr. Jane Green, an expert in the area of high genetic 
risk CRC in the province of NL, that there were no further communities that fit the required 
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description that could be sampled. The only remaining region of the province that had a familial 
cluster of high risk genetic CRC was the Twillingate / New World Island area. This region has 
familial clusters of AFAP. However, it was advised by Dr. Green that a pilot FOBT screening 
program had been running in that region for many years and a significant amount of research 
activity had also been conducted in this area. The high level of awareness of CRC in this region 
due to the screening program and previous research activity, coupled with the fact many 
residents were potentially already undergoing regular programmatic FOBT screening,  rendered 
this an inappropriate region to survey.  
 Final efforts were made through methods other than unaddressed admail to reach people 
in the original HRR region. Through a regional website, contact information was available for 
various groups that would likely have members in the desired age range. Letters, or where 
possible, emails, were sent to Anglican Church Women’s groups, United Church Women’s 
groups, the New-Wes-Valley 50+ club, the Royal Orange Lodge and the Lion’s Club. This did 
not lead to any further recruitment in this region. 
5.1.4 Round Three Mail-Out Survey 
 Round three mail-out activities were conducted in St. John’s and in the new ARR rural 
communities, as described above. Due to the $10 monetary incentive associated with round 
three, the projected response rate was higher. To account for this, the anticipated response rates 
for each region in round two were doubled and applied to the corresponding region in round 
three to calculate the number of packages that had to be sent to achieve the desired sample size. 
The outstanding sample size for the ARU region was 29, and with a proposed response rate of 
21%, 138 packages were required. Due to the overage, 148 packages were actually sent. 
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Seventeen completed, eligible surveys were returned for an 11.5% response rate, and seven 
completed ineligible surveys were returned for a total response rate of 18.1%.  
 The response rate from the round two mail out for the ARR area was 6%. Consequently, 
a projected 12% response rate was applied to round three. The remaining sample size was 165, 
requiring 1375 packages to be sent. With the overage, 1378 were mailed out. A total of 233 
completed, eligible surveys and 27 completed, ineligible surveys were returned for respective 
response rates of 16.9% (eligible) and 18.9% (total).  
 Combining both the telephone survey recruitment and all three mail-outs, there were 383 
ARU respondents, 434 ARR respondents and 142 HRR respondents in the total sample. The 
average response rates across all iterations of the mail-out survey process were 12.3%, 11.6% 
and 12.6% for ARU, ARR and HRR respectively.  The response rate for all respondents over all 
mail-outs was 12.2%. Required sample sizes were achieved for the ARU and ARR areas, but not 
the HRR area. Figure 5.1 portrays the recruitment process for the target population for screening 
survey.  
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Round 1 Mail-Out (Info Canada) 
 Average Risk Urban Area 
o 596 eligible surveys mailed, 90 eligible returned, 15.1% response 
rate 
 Average Risk Rural Area 
o 321 mailed, 321 returned to sender, 0% response rate 
 High Risk Rural Area 
o 168 eligible surveys mailed, 28 eligible returned, 16% response 
rate 
 
Round 2 Mail-Out (Canada Post, Unaddressed Admail) 
 Average Risk Urban Area 
o 2586 surveys mailed, 266 eligible returned, 10.3% response rate 
 Average Risk Rural Area 
o 2794 surveys mailed, 175 eligible returned, 6.3% response rate 
 High Risk Rural Area 
o 1209 surveys mailed, 112 eligible returned, 9.3% response rate 
 
Round 3 Mail-Out (Canada Post, Unaddressed Admail) 
 Average Risk Urban Area 
o 148 surveys mailed, 17 eligible returned, 11.5% response rate 
 Average Risk Rural Area 
o 1378 surveys mailed, 233 eligible returned, 16.9% response rate 
 
Totals 
 Average Risk Urban Area = 383 
 Average Risk Rural Area = 434 
 High Risk Rural Area = 142  
Total Sample Size: n = 959 
     
 
 
 
 
 
 
 
 
 
Figure 5.1 Recruitment Process for the Average Risk Population Survey  
Telephone Survey: 869 unique numbers called 
 38 Completed the survey 
 115 were not in service 
 100 declined to participate 
 208 did not meet eligibility criteria 
 404 did not answer 
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5.2. Total Sample 
 
5.2.1 Demographics 
Table 5.2 describes the demographic characteristics of and survey responses given by the 
total sample (n = 959). Women comprised slightly over half of the sample, 55.4%, and the mean 
age was 61 years, (SD = 6.5). The proportion of respondents in four of the five-year age 
subgroups was relatively similar, but was slightly lower in the 70-74 years subgroup at 11.8%. 
The majority of the sample were married, 70.3%, and 87% of respondents rated their health as 
good, very good or excellent.  
Table 5.2 Demographic Characteristics of the Total Sample 
Characteristic % (n) 
Gender Men: 43.9% (421) 
Women: 55.4% (531) 
Five-year Age Groups 50-54 years: 20.2% 
55-59 years: 22.5% 
60-64 years: 25% 
65-69 years: 19.6% 
70-74 years: 11.8% 
Marital Status Married: 70.3% 
Living as married: 5.3% 
Never married: 7.4% 
Divorced: 7.3% 
Separated: 1.4% 
Widowed: 7.3% 
Health Status Excellent: 13.8% 
Very Good: 39.3% 
Good: 33.8% 
Fair: 11.2% 
Poor: 1.3% 
 
 
5.2.2 FOBT Awareness and Prior Use 
Approximately two-thirds of the sample (67.3%) reported that they had heard of an 
FOBT test prior to reading a description of this test as a part of the survey. Approximately two-
thirds of the sample reported that they not been screened using FOBT in the past (67.5%).  
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5.2.3 Intention to Screen Using FOBT 
Respondents were asked about their intention to screen using two different approaches. 
First they were asked: Which statement best describes how you feel about using the fecal occult 
blood test when it becomes available in your region? Possible response categories were: ‘I would 
not complete a fecal occult blood test if one were sent to my home’, ‘I am unsure if I would 
complete a fecal occult blood test if one were sent to my home’ or ‘I would definitely complete a 
fecal occult blood test if one were sent to my home’.  
A positive intention to screen if an FOBT were sent to their home was reported by 79.2% 
of respondents (definitely screen), followed by 14.9% who were uncertain if they would screen, 
and 4.5% who reported that they would not complete the test.   
Secondly, respondents were asked to circle how likely is was that they would complete a FOBT 
if one were sent to them at home. Respondents could choose a numerical value between 1 and 
10, where 1 represented ‘I would definitely not complete a fecal occult blood test’ and 10 
represented ‘I would definitely complete a fecal occult blood test’.  Table 5.3 displays the 
response distribution for this question. Responses to both questions on intention to screen 
demonstrated that there was high positive intention to screen among the sample.   
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Table 5.3 Response Distribution for 10-Point Scale Intention to Screen Question 
Response Frequency Percent 
1 50 5.2 
2 10 1.0 
3 6 0.6 
4 15 1.6 
5 53 5.5 
6 35 3.6 
7 31 3.2 
8 77 8.0 
9 66 6.9 
10 602 62.8 
Missing 14 1.5 
Total 959 100 
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5.3 Sample Characteristics and Survey Responses by Presence / Absence of High Risk CRC  
 
Sample characteristics and survey responses were examined by the three distinct 
populations. Table 5.4 compares the sample characteristics and survey responses by the ARU, 
ARR and HRR areas.  
The sample from each region had a similar gender breakdown (p = 0.79) and mean age (p 
= 0.59). The highest proportion of respondents were aged 60-64 for all regions. Fewer 
respondents in the ARU area were married, and more were divorced compared with the other 
two areas (p = 0.00). Urban respondents were more likely to report their health status as 
‘Excellent’ or ‘Very Good’ (p = 0.02). The most frequently chosen response to health status in 
the ARR and HRR regions was ‘Good’.  
Those in the ARR region were most likely to have heard of FOBT before (75.3%), 
followed by the ARU population (62%) and then the HRR population (57%), p = 0.00. 
Additionally, those in the ARR population were approximately twice as likely as those in the 
other two areas to have previously screened using FOBT, 41.2%, versus 23.4% and 19% in ARU 
and HRR populations, respectively (p = 0.00). Overall, 30.9% of respondents reported previous 
screening activity using FOBT, indicating that many respondents had not used the test before.  
With respect to intention to screen using FOBT, a high proportion responded ‘yes’ to the 
intention to screen question in each of the three areas. As with prior awareness of FOBT, the 
ARR sample had the highest proportion of positive intention (82.9%), followed by the ARU 
sample (79.6%) and the HRR sample (77.1%). All three regions had very low proportions of 
respondents who said they would not complete an FOBT if one were sent to their home (< 7% in 
total). The HRR group was more likely to report uncertain intention to participate in FOBT 
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screening (20.7%) when compared with the other two groups (ARU = 15% and ARR = 13.3%), 
p = 0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
107 
 
Table 5.4 Sample Characteristics and Survey Responses by Geography/Risk Level  
Survey Item Response  Significant 
Gender (%) Gender ARU ARR HRR Total  No 
p =  0.79 Male 45.3 43 45.1 44.2 
Female 54.7 57 54.9 55.8 
Missing: 7 cases 
Mean Age 
(years) 
Mean Age  ARU ARR HRR Total  No 
p = 0.59 61  61.1 60.3 60.9 
Missing: 7 cases 
Age Group 
(%) 
Age Group ARU  ARR HRR Total  No 
p  = 0.15 50-54 22 18.2 22.5 20.4 
55-59 22.5 22.9 23.2 22.7 
60-64 23.1 26.4 27.5 25.2 
65-69 17.3 22.4 18.3 19.8 
70-74 15.2 10 8.5 11.9 
Missing: 9 cases 
Marital 
Status (%) 
Marital 
Status 
ARU ARR HRR Total  Yes 
p = 0.00 
Married 61.3 78.9 73.2 71 
Living as 
Married 
5.5 4.9 6.3 5.4 
Never 
Married 
11.3 4.0 7.7 7.5 
Divorced 12.6 3.7 4.2 7.4 
Separated 2.4 0.7 0.7 1.4 
Widowed 6.8 7.7 7.7 7.4 
Missing:10 cases 
Health Status 
(%) 
Health 
Status 
ARU ARR HRR Total  Yes 
p  = 0.02 
Excellent 18.8 10.3 11.3 13.9 
Very Good 40.7 40.3 34.5 39.6 
Good 29.5 36.1 40.1 34 
Fair  9.9 11.9 12.7 11.2 
Poor 1.0 1.4 1.4 1.3 
Missing: 7 cases 
Heard of 
FOBT Before 
Survey (%) 
Heard of 
FOBT 
ARU ARR  HRR Total  Yes 
p = 0.00 
Yes 62 75.3 57.9 67.5 
No 38 24.7 42.1 32.5 
Missing: 3 cases 
Prior Use of 
FOBT (%) 
Prior 
FOBT 
ARU ARR HRR Total Yes 
p = 0.00 
Yes 23.4 41.2 19 30.9 
No 76.6 58.8 81 69.1 
Missing: 23 cases 
Intention to 
Screen 
Intent ARU ARR HRR Total  Yes 
p  = 0.05 
 
 
Definitely 78.6 82.9 76.1 79.2 
Unsure 15 13.1 20.4 14.9 
No 6.3 3.7 2.1 4.5 
Missing: 13 cases 
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5.4 Univariate Analysis  
5.4.1. Data Amalgamation Considerations – Average Risk Populations 
Before further analysis was undertaken, a chi square test was performed to determine if 
the two average risk populations differed from each other on their reported screening intentions. 
Based on prior findings of lower engagement in preventive health behaviours in rural 
populations, the secondary study hypothesis stated that individuals residing in an ARU region 
would be more likely to report a positive intention to screen than ARR dwelling individuals. If 
no significant difference was found between these two groups, this hypothesis would not be 
supported and the two populations with no familial clusters of high risk CRC would be collapsed 
into one group called ‘average risk’ for the remainder of the analysis. Table 5.5 shows the results 
of the cross-tabulation comparing the ARU and ARR populations on intention to screen. No 
significant difference was detected between these groups on intention to screen, [χ2 = 3.56 (2), p 
= 0.17]. This does not support the hypothesis of a significant difference on reported screening 
intention between these two groups.   
Table 5.5 Average Risk Populations by Intention to Screen 2x3 Table 
Region of Province 
Intention n (%) 
Total No Unsure Yes 
Average Risk Urban 24 (6.3) 57 (15) 298 (78.6) 379 
Average Risk Rural 16 (3.7) 57 (13.3) 354 (82.9) 427 
Total 40  114  652  806 
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5.4.2 Data Amalgamation Considerations – Intention to Screen Response Categories 
The option was also explored of grouping the ‘unsure’ and ‘no’ responses to the 
screening intention question into one response category for remaining analysis. Very small 
numbers of respondents chose the ‘unsure’ and particularly the ‘no’ categories in each region 
leading to small cell sizes that could impact the validity of univariate and multivariate analyses. 
 Given that the study’s principal focus was on whether or not those living in areas where there 
was a familial cluster of high risk CRC differed on positive screening intention from those living 
in areas where there was no such cluster, it was felt that collapsing the ‘unsure’ and ‘no’ 
categories warranted examination to see if it would alter the results. If a similar relationship was 
found using two response categories compared with the original three, then ‘yes’ and ‘unsure / 
no’ would be used going forward for parsimony of analyses.  
Tables 5.6 and 5.7 demonstrate the cross-tabulation and chi-square analysis for presence / 
absence of high risk CRC by screening intention, retaining the original three response categories. 
Tables 5.8 and 5.9 demonstrate the same statistics, excepting that screening intention is a 
dichotomous variable.  
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Table 5.6 Presence / Absence of High Risk CRC by Screening Intention 2x3 Table 
Region of Province 
Intention n (%) 
Total No Unsure Yes 
Average Risk 40 (5.0) 114 (14.1) 652 (80.9) 806 
High Risk 3 (2.1) 29 (20.7) 108 (77.1) 140 
Total 43  143 760  946 
 
 
 
 
 
Table 5.7 Presence of High Risk CRC by Screening Intention (Three Response Categories) 
Chi Square Analysis  
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 5.70 2 0.06 
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Table 5.8 Presence of High Risk CRC by Screening Intention 2x2 Table 
Region of Province  
Intention 
Total Unsure / No Yes 
Average Risk 154 (19.1) 652 (80.9) 806 
High Risk 32 (22.9) 108 (77.1) 140 
Total 186  760  946 
 
 
 
 
 
 
 
 
Table 5.9 Presence of High Risk CRC by Screening Intention (Two Response Categories) 
Chi Square Analysis  
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 1.06 1 0.30 
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Based on non-significant findings on screening intention using either two or three 
response categories, and the very small number of participants reporting a negative intention to 
screen (5% in the combined average risk region and 2.1% in the high genetic risk region), it was 
decided that collapsing the ‘no’ and ‘unsure’ response categories into one category for 
comparison against those reporting a positive intention to screen was a methodologically 
justifiable decision.  The combined average risk regions (cAR) and the HRR region had high and 
similar rates of reported positive screening intention (80.9% and 77.1% respectively), p = 0.30. 
This finding refutes the study hypothesis that those living in an area with the presence of a 
familial cluster of high genetic risk of CRC would be more likely to report positive screening 
intention than those living in areas where high genetic risk CRC familial clustering was not 
found. Further analyses were conducted to determine if other demographic factors played a 
significant role in impacting screening intention in the NL population.  
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5.4.3 Ten-Point Screening Intention Variable 
An additional item on the average risk population survey that addressed screening 
intention was also examined in relation to presence / absence of familial clusters of high genetic 
risk CRC to determine whether asking about screening intention an alternative way yielded the 
same or different outcomes. This question asked respondents to choose on a scale of 1 to 10 how 
likely they would be to complete an FOBT if one were sent to them. As the independent variable 
was nominal and the dependent variable was ordinal, non-parametric tests other than chi-square 
were used for analysis.  
 A Kruskal-Wallis test was first run, keeping the independent variable of ‘Region’ as three 
distinct groups. As seen in Table 5.10, no significant difference was found between ARU, ARR 
and HRR respondents on the response distribution for screening intention.  
 
Table 5.10 Kruskal-Wallis Test of Screening Intention by Region (Three Categories) 
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 Subsequent to this, the two average risk regions were collapsed into one category, 
making the independent variable two-category. A Mann-Whitney U test was then run comparing 
the two groups on screening intention. No significant difference was found in response 
distributions between the two groups.  
 
 
Table 5.11 Mann-Whitney U Test of Screening Intention by Region (Two Categories) 
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5.4.4 Intention to Screen by Socio-Demographic Characteristics and FOBT Awareness 
/Prior Use       
 
Following the chi square analyses run for the primary outcome of interest: relationship of 
presence / absence of a familial cluster of high genetic risk CRC and intention to screen, chi-
square analyses were run for each socio-demographic variable by reported screening intention 
and for responses on FOBT awareness and prior use by reported screening intention to determine 
if any of these factors had a significant relationship with intention to screen. All chi square 
analyses that were significant at the p ≤ .10 level were retained for inclusion in multivariate 
analysis.  
There was no significant difference in screening intention by gender, [χ2 = 0.01 (1), p = 
0.91]. The proportion of respondents choosing each response category were similar for men and 
women. This variable was not retained for multivariable analysis.  
 
Table 5.12 Gender by Intention to Screen 2x2 Table 
Gender 
Intention n (%) 
Total Unsure / No Yes 
Male 
 
83 (20) 333 (80) 416 
Female 
 
103 (19.7) 421 (80.3) 524 
Total 
 
186 754 940 
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Age was collapsed into five-year subgroups for the purpose of analysis by age. No 
significant difference was found on screening intention by five-year age group, [χ2 = 4.23 (4), p = 
0.38]. All age groups were likely to report a positive screening intention, although those in the 
50-54 age group were slightly less likely to choose ‘yes’ on screening intention than those in the 
older groups. Age group was not retained for multivariable analysis.  
 
Table 5.13 Five-Year Age Group by Intention to Screen 5x2 Table 
Age Group 
Intention n (%) 
Total Unsure / No Yes 
50-54 47 (24.5) 145 (75.5) 192 
55-59 41 (19.2) 173 (80.8) 214 
60-64 43 (18.2) 193 (81.8) 236 
65-69 31 (16.7) 155 (83.3) 186 
70-74 22 (19.8) 89 (80.2) 111 
Total 184 755 939 
 
 
Health status was reduced from five response categories down to three by grouping 
‘poor’ / ‘fair’ into one category and ‘very good’ / ‘excellent’ into one category. This was done to 
avoid cells containing counts < 5  in the chi square analysis because very few respondents chose 
‘poor’ or ‘fair’ to represent their health status. The majority of respondents reported a positive 
intention to screen despite their health status.  A slightly higher proportion of those whose 
considered their health ‘Very Good’ or ‘Excellent’ answered in the ‘Yes’ category compared 
with those who considered their health ‘Good’. In turn, those who considered their health ‘Good’ 
were slightly more likely to report a positive intention to screen than those in the ‘Poor / Fair’ 
health status category. Chi square analysis was significant at < the 0.10 level, so health status 
was retained for multivariate analysis, [χ2 = 4.64 (2), p = 0.09].  
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Table 5.14 Health Status by Intention to Screen 3x2 Table 
Health Status 
Intention n (%) 
Total Unsure / No Yes 
Poor/Fair 29 (24.8) 88 (75.2) 117 
Good 70 (21.8) 251 (78.2) 321 
Very Good / Excellent 87 (17.3) 416 (82.7) 503 
Total 186 755 941 
 
 
Marital status was grouped into two categories of ‘married’ / ‘living as married’ and 
‘never married’ / ‘separated’ / ‘divorced’ / ‘widowed’ to distinguish those who were living in 
partnership from those who were not. A number of the available response categories for marital 
status were chosen infrequently, which was an additional reason to collapse across categories. 
Individuals who were currently in a partnership chose a positive intention to screen slightly more 
often than those who were un-partnered. This difference was not significant, [χ2 = 1.74 (1), p = 
0.19], and this variable was not retained for multivariate analysis. 
 
 
Table 5.15 Marital Status by Intention to Screen 2x2 Table 
Marital Status 
Intention n (%) 
Total Unsure / No Yes 
Married/Living as Married 134 (18.7) 583 (81.3) 717 
Not married 50 (22.7) 170 (77.3) 220 
Total 184 753 937 
 
 
Those who had heard of FOBT before were more likely to report a positive intention than 
those who had not heard of it, 85.3% versus 70.2%. Prior awareness of FOBT appeared to reduce 
uncertainty and increase positive intention to complete FOBT in this sample. The difference on 
intention to screen between those who had heard of FOBT and those who had not was 
significant, [χ2 = 30.05 (1), p = 0.00]. This variable was retained for multivariate analysis.  
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Table 5.16 Prior FOBT Awareness by Intention to Screen 2x2 Table 
Prior Awareness of FOBT 
Intention n (%) 
Total Unsure / No Yes 
No 92 (29.8) 217 (70.2) 309 
Yes 93 (14.7) 541 (85.3) 634 
Total 185 758 943 
 
 
 
Those who had used FOBT in the past were less likely to report uncertainty or negative 
intention about completing an FOBT if one were sent to them. Almost 90% of those who 
completed an FOBT prior to taking the survey said they would definitely complete an FOBT if 
they received one compared with 15% less of those who had never used FOBT (76.7%).  The 
association between prior FOBT use and intention to screen was significant, [χ2 = 19.99 (1), p = 
0.00], and thus this variable was also retained for multivariate analysis.  
 
Table 5.17 Prior FOBT Use by Intention to Screen 2x2 Table 
Prior Use of FOBT 
Intention 
Total Unsure / No Yes 
No 149 (23.3) 490 (76.7) 639 
Yes 31 (10.8) 257 (89.2) 288 
Total 180 747 927 
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5.4.5 Univariate Analysis Summary 
 Analyses conducted at the univariate level suggested rejecting the study hypothesis. The 
majority of respondents reported a positive intention to engage in screening regardless of the 
presence or absence of a familial cluster of high genetic risk CRC in the region in which they 
were residing. Rurality of geography did not appear to make a difference, given that there was no 
significant difference in intention to screen between those residing in urban or rural regions 
where there was no cluster of high risk CRC. Those variables that were significant at the p ≤ 0.1 
level were retained for multivariate analysis and included health status, prior awareness of FOBT 
and prior use of FOBT. As the primary predictor of interest, presence or absence of high risk 
CRC was also retained for multivariable analysis, even though it did not meet the significance 
criteria. Table 5.18 provides a summary of all univariate analysis conducted and which variables 
were retained for multivariable analysis.  
 
 
Table 5.18 Summary of Univariate Analysis Conducted on the Relationship between 
Target Population Survey Variables and Intention to Screen 
Variable Statistic Value [df] Significance Level Retained 
Presence / Absence 
of High Risk CRC 
χ2 1.06 [1] p = 0.30 √ 
Gender χ2 0.01 [1] p = 0.91 X 
Age Group χ2 4.23 [4] p = 0.38 X 
Health Status χ2 4.64 [2] p = 0.09 √ 
Marital Status χ2 1.74 [1] p = 0.19 X 
Prior Awareness of 
FOBT 
χ2 30.05 [1] p = 0.00 √ 
Prior Use of FOBT χ2 19.99 [1]  p = 0.00 √ 
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5.5 Multivariate Analysis 
 
5.5.1 Logistic Regression 
Because the dependent variable (screening intention) was treated dichotomously, (yes or 
no/unsure), binomial logistic regression was used to conduct multivariate analysis. Logistic 
regression was chosen over discriminant analysis because it requires fewer assumptions and is 
more statistically robust130.  Logistic regression employs binomial probability theory in which 
there are only two values to predict: that probability (p) is 1 rather than 0. It forms a best fitting 
equation of function using the maximum likelihood method, which maximizes the probability of 
classifying the observed data into the appropriate category given the regression coefficients. 
Each independent variable has a β-coefficient that measures each independent variable’s 
contribution to changes in the dependent variable. A minimum of 50 cases per independent 
variable is recommended130. Binomial logistic regression produces an odds ratio which estimates 
the change in the odds of membership in the target group for a one unit increase in the predictor.  
In the case of this analysis, predictor values that were significant at the p < 0.1 level using chi-
square analysis, were retained for inclusion in a multivariate model. These included health status, 
prior awareness of FOBT and prior use of FOBT. Although, not significant in univariate 
analysis, the presence / absence of high genetic risk was maintained for multivariate analysis 
given that it was the primary predictor variable of interest.  
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5.5.2 Model Summary  
The overall significance of the model was tested using the Model Chi Square. This is derived 
from the likelihood of observing the actual data under the assumption that the model that has 
been fitted is accurate. The null hypothesis is that the model is a good fit without any predictors 
added. Table 5.19 shows that the model chi-square has a value of 37.18, three degrees of 
freedom and a probability of p < 0.00. Thus, the indication is that the model has a poor fit when 
it contains only the constant, and the inclusion of predictors does have a significant effect and 
create a different model.  
 
5.19 Model Chi-Square 
 Chi-square df Sig. 
Step 1 Step 37.25 4 0.00 
Block 37.25 4 0.00 
Model 37.25 4 0.00 
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5.5.3 Logistic Regression Results  
Table 5.20 shows the logistic regression output when prior awareness of FOBT, prior use 
of FOBT, health status and presence or absence of high genetic risk are entered into the logistic 
regression model. The Wald statistic shows that all variables included make a significant 
contribution to the prediction except presence or absence of high genetic risk. P-values for the 
three significant predictors were prior awareness (p = 0.001), prior use (p = 0.008) and health 
status (p = 0.05). The Exp(B) column shows the odds ratio for each variable. The odds of 
reporting a positive screening intention were more likely if the person had heard of FOBT 
before, [OR = 1.92, 95% CI 1.32 - 2.77]; if the person had used FOBT before [OR = 1.87, 95% 
CI 1.18 - 2.97] and, as self-reported health status improved [OR = 1.27, 95% CI 1.00 - 1.60]. The 
confidence intervals for both prior awareness and prior use of FOBT were narrow and did not 
cross one, which indicates reasonable reliability and significance of the estimate. The lower limit 
of the confidence interval for health status approached one, which calls into question the 
significance of this predictor in the model. When presence or absence of high genetic risk was 
removed and the model rerun, the results for the remaining three variables remained almost the 
same.  
 
Table 5.20 Logistic Regression Output 
 
 
 
Variable  B S.E. Wald df Sig. Exp(B) 
95% C.I.for EXP(B) 
Lower Upper 
Prior Awareness 
FOBT 
0.65 0.19 11.84 1 0.001 1.92 1.32 2.77 
Prior Use FOBT 0.63 0.24 7.13 1 0.008 1.87 1.18 2.97 
Health Status 0.24 0.12 3.92 1 0.05 1.27 1.00 1.60 
Presence of Risk 0.07 0.24 0.07 1 0.79 1.07 0.67 1.70 
Constant 0.28 0.32 0.78 1 0.38 1.32   
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Chapter Six 
Results: Family Physician Survey 
6.1 Sample Recruitment and Response Rate 
 The intended population for the family physician survey was all family physicians 
practicing in NL. The Primary Health Research Unit of the Faculty of Medicine, Memorial 
University maintains a family physician database that is updated frequently. This database was 
accessed for the mail-out. As explained in the methodology chapter, the Dillman129 method was 
used to enhance response rate. This involved three iterations of survey mail-outs in which non-
responders in each round were sent a survey in the subsequent round.  
6.1.1 Round One Mail-Out 
 In the first mail-out, 586 surveys were mailed to the individuals included in the family 
physician database. Of these, 15 were returned unopened as ‘return to sender’ and two were 
returned with notes stating that the physician to which the survey was sent was not practicing in 
the primary care setting. Out of an eligible denominator of 569 then, 140 completed or partially 
completed surveys were returned for a response rate of 24.6%.  
6.1.2 Round Two Mail-Out 
 It was recognized that surveys from some physicians who had responded to the round one 
mail-out would not have been received by the time the round two mail out was initiated. Thus, 
some physicians would receive a second survey package even though they had already sent a 
response. This was acknowledged in the information letter that was sent in the round two survey 
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package. Those who had already returned a survey were asked to disregard the second mailing. 
In total, 482 surveys were mailed out in round two. Four packages were returned unopened and 
three were returned with notes explaining why the physician to which the survey was sent was 
not in the correct target group.  Eighty-one surveys were returned out of an eligible 475 mailed 
for a response rate of 17.05%.  
6.1.3 Round Three Mail-Out 
 A total of 409 survey packages were sent out in round three. A similar message was 
included in the round three information letter acknowledging that some physicians had possibly 
already returned a survey and, if so, asking them to disregard the follow-up mail-out. Five 
surveys were returned unopened and an additional four were returned with note stating that the 
physician was not involved in primary care. These nine surveys were discounted from the 
denominator total.  Round three resulted in a response rate of 13.25% (53/400).  
6.1.4 Response Rate Summary 
Table 6.1 summarizes the response rates attained over the three rounds of survey mail- 
outs. After discounting all surveys sent back as ‘return to sender’ or sent back indicating that the 
survey had been received by an individual who was not practicing primary care (33), the final 
denominator of eligible individuals was 553. Over the three rounds of mail outs, 274 surveys 
were returned either completed or partially completed. This resulted in a final response rate of 
49.6% for the family physician survey.  
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Table 6.1 Family Physician Survey Response Rate Summary 
Mail Out Surveys Sent Surveys Eligible Surveys Returned Response Rate 
1 586 569 140 24.6% 
2 482 475 81 17.1% 
3 409 400 53 13.3% 
Total    49.6% 
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6.2 Survey Results 
6.2.1 Sample Demographics 
 Of the 274 family physicians who responded to the survey, 158 (57.7%) were male. The 
mean age of respondents was 47.6 (SD = 11.5) years of age and the median year of graduation 
was 1991. The majority of respondents graduated from a Canadian medical school, (70.8%), and 
62.8% had their practice located in the Eastern Regional Health Authority. The split between 
urban and rural practices was almost equal and most physicians were practicing full-time. 
Physicians saw a mean of 131.2 (SD = 61.7) patients per week and 72.6% were practicing in a 
family physician office / clinic spending on average 40.7 (SD = 12.3) hours per week in direct 
patient care. The mean number of additional physicians per office was 3.57 (SD = 3.67). Table 
6.2 and Figures 6.1-6.5 provide a description of the family physician sample.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
Table 6.2 Family Physician Respondent Characteristics 
Survey Item Response  
Gender Female: 114 (41.6%) 
Male: 158 (57.7%) 
Missing: 2 
Median Age 45 years (range: 23-73 years)  
Missing: 6 
Median Year of Graduation 1991 (range: 1966-2011) 
Missing: 9 
Medical School Canadian: 194 (70.8%) 
International: 69 (25.2%) 
Missing: 11 
Location of Practice by RHA Eastern Health: 172 (62.8%) 
Central Health: 48 (17.5%) 
Western Health: 33 (12%) 
Labrador-Grenfell Health: 20 (7.3%) 
Missing: 1 
Time Spent in Practice Full-Time: 223 (81.4%) 
Part-Time: 38 (13.9%)  
Locum: 5 (1.8%) 
Other: 5 (1.8%) 
Missing: 3 
Location of Practice by Urban / Rural Urban: 135 (49.3%)  
Rural: 134 (48.5%) 
Missing: 6 
Median Number of Patients per Week 122.5 (range: 15-350 patients) 
Missing: 6 
Clinic Setting Family Practice Office/Clinic: 199 (72.6%) 
Long Term Care: 1 (0.4%) 
Emergency Room: 19 (6.9%) 
In-patient Based: 5 (1.8%) 
Walk-In: 5 (1.8%) 
Other: 13 (4.7%) 
Missing: 32 
Mean Hours / Week in Direct Patient Care 40.7 (range: 6-100 hours) 
Missing: 6 
Mean Number of Physicians in Practice 3.57 (range: 0-30 physicians) 
Missing: 25 
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Figure 6.1 Physician Age Group 
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Figure 6.2 Year of Graduation from Medical School  
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Figure 6.3 Number of Patients Seen Per Week 
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Figure 6.4 Number of Hours Spent in Direct Patient Care Per Week  
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Figure 6.5 Number of Physicians in Practice  
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6.2.2 Responses to Screening Questions 
 Physicians were asked a variety of questions regarding their knowledge, beliefs and 
practices with respect to FOBT screening for CRC. These are described in the various tables and 
figures below. Question 1 asked ‘Before receiving this information letter and survey, were you 
aware of fecal occult blood testing (FOBT) as a screening modality for colorectal cancer?’ All 
respondents reported having awareness of FOBT prior to receiving the survey. 
 The mean levels of agreement for questions 2a and 2b, 5.79 and 5.11 respectively, 
indicated a high level of agreement with both statements. Family physicians felt particularly 
strongly about having a role to play in support and advocacy for CRC screening. They also 
agreed that they effectively communicated with their patients about CRC screening, with 75% 
choosing response categories 5 or 6. However, there was more variability over categories 4, 5 
and 6 in response to question 2b when compared with question 2a. This suggests more 
uncertainty is felt by physicians in how effectively they communicate with their patients 
regarding CRC screening. 
Table 6.3 (Questions 2a and 2b.)  Please indicate your level of agreement with the following 
statements: 2a. Family Physicians have a responsibility to support and advocate for 
colorectal cancer screening &2b. I effectively communicate colorectal cancer screening 
strategies to my patients. 
Question n Strongly 
Disagree 
1 
2 3 4 5 Strongly 
Agree 
6 
Agreement 
5+6 
Weighted 
Mean 
2a 273 0% 0% 0.7% 3.3% 16.8% 79.1% 95.9% 5.79 
2b 273 0% 1.1% 1.5% 22.3% 35.5% 39.6% 75.1% 5.11 
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 Question 3 explored various potential barriers to discussing CRC screening in the 
family practice environment. Combining the ‘often’, ‘most of the time’ and ‘always’ categories 
clearly demonstrated that many of these items were not perceived to be barriers for the family 
physicians responding to this survey. In particular, physician financial compensation, comfort 
level with knowledge of CRC screening options and perceived patient fear or embarrassment 
about the screening procedure did not appear to be significant barriers.  
 The time required to explain the pros and cons of screening options was reported to be 
a barrier ‘often’, ‘most of the time’ or ‘always’ by almost 20% of physicians, however, almost 
half (48.9%) felt this was a barrier ‘never’ or ‘rarely’ and 31.6% reported that it was a barrier 
‘sometimes’. The presence of co-morbid conditions in patients at average risk for CRC was seen 
to be the biggest barrier to discussing screening with 40.9% of physicians choosing ‘often’, 
‘most of the time’ or ‘always’ in response to this question. Nonetheless, the remaining 60% 
chose one of the lower three response categories. Of the barriers listed in the survey, none 
emerged as being a frequent barrier by the majority of the physician sample.  
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Table 6.4 (Question 3.) The following factors are barriers to discussing colorectal cancer screening with my average risk 
patients.  
Factors n Never 
1 
2* 3± 4‡ 5^ Always 
6 
4 + 5+ 6 Weighted 
Mean 
Physician financial compensation 270 61.5% 17.5% 13.5% 4.0% 1.5% 1.5% 7.0% 1.70 
Level of comfort with my knowledge to help 
patients decide pros/con of CRC screening 
options 
271 43.2% 37.3% 14.4% 2.6% 2.2% 0.4% 5.2% 1.85 
Time it takes to explain the pros/cons of CRC 
screening options 
272 26.1% 22.8% 31.6% 12.5% 5.5% 1.5% 19.5% 2.54 
Patients with multiple health issues 271 16.2% 12.9% 29.9% 28.0% 11.8% 1.1% 40.9% 3.10 
Patients fear/embarrassment about the 
screening procedure 
271 39.5% 28.8% 19.2% 8.9% 2.6% 1.1% 12.6% 2.10 
* Rarely  ± Sometimes  ‡Often  ^Most of the Time   
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 Question 3 also included an ‘other’ category that invited respondents to specify other 
barriers not listed in the survey and to indicate the frequency with these impacted the ability to 
discuss CRC screening. Only 13 physicians identified additional barriers and some of these 
related to the barriers already listed in the survey. It is unknown why the barriers, as they were 
worded, did not adequately capture the experience for certain physicians.  Responses from this 
small number of respondents revealed that financial compensation, competing patient issues, 
time available with the patient, availability of FOBT kits in the physician’s office, patient uptake 
of colonoscopy, and health system inability to cope with increased colonoscopy demand were all 
barriers.   
Examples of physician quotes are provided below: 
“Too many other more important issues” 
“Have so many issues to address on visit and not compensated for time with patient” 
“Must have kits ready and available” 
“Physical restraints, not having testing available” 
“Very poor response for booking patient for screening colonoscopy”     
“The system in Labrador could not handle the one of three positive screens that would be 
generated in a 10-year follow-up / screening program. Access to endoscopy etc.”                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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 Question 4 on the survey asked physicians about the age at which they started 
screening their patients who are average risk for CRC. This question was designed to understand 
whether physicians were practicing according to screening guidelines which recommend 
beginning screening at age 50 for individuals at average risk for CRC.  Table 6.5 displays these 
results which demonstrate that almost 85% of respondents reported practicing according to the 
recommended guideline for beginning CRC screening at age 50. Only 5.1% reported that they 
did not routinely recommend CRC screening.  
Table 6.5 (Question 4) I routinely start recommending colorectal cancer screening to my 
average risk patients when they are:  
Age Percentage Reporting (n) 
<50 8.8 (24) 
50 83.5 (228) 
>50 2.6 (7) 
I do not routinely recommend CRC cancer 
screening 
5.1 (14) 
 
 For those who reported that they did not routinely recommend CRC screening (14 
respondents), Question 5 provided an opportunity to explain the rationale behind this. Again, 
time available during the patient visit was cited to be a factor, as was the health system’s 
inability to cope with follow-up colonoscopy demand. Three physicians mentioned that they 
preferred not to screen their patients unless they were symptomatic or otherwise at an increased 
risk for CRC (which is counter to the recommendation of FOBT screening for average-risk, 
asymptomatic patients), and one physician stated that very few of their patients would qualify as 
average risk, rendering FOBT inappropriate for most of their patient population. Two physicians 
reported being unsupportive of FOBT as a screening modality. Examples of reasons for not 
routinely recommending CRC screening to average risk patients included: 
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“Do not have time to get occult blood on all patients over age 50. We have so much colon cancer 
that our medical services (scopes) is over loaded now. Mass screening with occult blood would 
make the colonoscope wait time laughable. So need to select the patients I ask to get occult 
blood. Also not comfortable with occult blood screening but do support scope every 5 years.” 
 
“I ask if there is any family history or colon cancer / polyps or in the patient has any lower GI 
symptoms. If no family history of colon cancer, colonic polyps, no change in bowel habit, no per 
rectum blood and CBC and LFTs normal I don't pursue any further.” 
 
“I discuss colorectal cancer screening with most of my patients starting around 45 years old, but 
most have some clinical risk factors justifying referral for colonoscopy. The few that don't I 
would probably request FOB testing.” 
 
“Referral for colonoscopy is extremely unreliable in this area.” 
 
“Whereas stools for occult blood are available, I have little faith in it. Colorectal scoping is not 
easily obtainable and it is a source of endless grief!!” 
 
“Generally there is a focused agenda around each of the visits and often you remember to 
discuss colorectal screening after the patient has left.” 
  
Following from enquiry about the patient age at which screening is started, Question 6 asked 
physicians to provide the age at which they routinely stopped recommending CRC screening to 
their average risk patients. As with Question 4, this question was designed to investigate whether 
physicians were following the recommendation to stop average risk screening at age 74. Table 
6.6 displays the distribution of responses. Ages 74 and 75 were both accepted as correct 
responses given that the recommended screening age range is 50-74 years. Stopping screening at 
age 75 could imply that the physician stopped screening at the end of a patient’s 74th year of age, 
which would be appropriate. It was clear from responses that adherence to the recommendation 
that screening be terminated at age 74 was relatively low. Roughly half of physicians reported 
that they did not stop screening at a particular age, and only a quarter complied with the 
recommend guideline.  
 
 
 
139 
 
Table 6.6 (Question 6.) I routinely stop recommending colorectal cancer screening to my 
average risk patients when they are:  
Age Number Reporting (%) 
<74 17 (6.4) 
74 or  75 66 (25) 
>75 53 (20) 
I do not routinely stop CRC screening 128 (48.6) 
 
Question 7 explored the types of CRC screening testing that physicians were utilizing 
with their average risk patients and the frequency with which they utilized each type of test. A 
summary of responses is illustrated in table 6.7. Responses to Question 7 show that colonoscopy 
was the most frequently used screening method for average risk patients by family physician 
respondents in NL. This is counter to the 2010 CAG position paper which recommends FOBT 
annually or biennially, or flexible sigmoidoscopy every five years for programmatic screening of 
the average risk population. Only half of respondents reported using FOBT ‘often’, ‘most of the 
time’ or ‘always’, while approximately 40% and 34% chose these response categories 
cumulatively for digital rectal exam with home FOBT and digital rectal exam with office FOBT 
respectively. Surprisingly, just over a quarter of the sample chose the highest three response 
categories for digital rectal exam only. One-fifth of respondents used flexible sigmoidoscopy, 
‘often’, ‘most of the time’ or ‘always’, and double-contrast barium enema and CT colonography 
were used infrequently. Percentages across the different screening modalities did not sum 
to100% as an answer could be provided by each physician for each type of procedure.  
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Table 6.7 (Question 7.) I recommend the following procedures to my average risk patients 
for colorectal cancer screening: 
Procedures n Never 
1 
2* 3± 4‡ 5^ Always 
6 
4 + 5+ 
6 
Weighted 
Mean 
Digital Rectal Exam 
Only 
237 37.1% 18.1% 12.8% 9.1% 10.6% 6.2% 25.9% 2.64 
Digital Rectal Exam 
with office FOBT 
239 32.2% 13.8% 20.1% 14.6% 12.6% 6.7% 33.9% 2.82 
Digital Rectal Exam 
with home FOBT 
241 18.7% 14.1% 27.4% 14.5% 17.8% 7.5% 39.8% 2.80 
FOBT completed at 
home only 
238 19.7% 12.2% 16.8% 16.8% 24.4% 8.8% 50% 3.44 
Double-contract 
barium enema 
237 29.1% 42.6% 23.2% 3.8% 1.3% 0% 5.1% 2.05 
Flexible 
sigmoidoscopy 
237 19.4% 27.0% 32.9% 13.5% 5.1% 1.8% 20.4% 2.64 
Colonoscopy 251 6.8% 11.6% 21.1% 25.5% 23.9% 11.2% 60.6% 3.82 
CT colonography 236 23.3% 28.8% 35.6% 10.2% 2.1% 0% 12.3% 2.39 
* Rarely  ± Sometimes  ‡Often  ^Most of the Time 
 Question 8 offered respondents the opportunity to articulate whether they recommended 
any other screening procedures for CRC to their patients. Only four family physicians provided a 
response to this question. Two of these listed procedures from the aforementioned list in 
Question 7, and two mentioned blood work (complete blood count and carcinoembryonic 
antigen).  
 The frequency with which family physicians recommended FOBT screening was explored 
in Question 9. The recommended frequency of programmatic screening using FOBT, as 
mentioned above, is annually or biennially, which were the frequencies chose by almost 90% of 
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physicians. This implies that almost all family physicians who are using FOBT screening with 
their patients are aware of and practicing according to an appropriate screening interval.  
Table 6.8 (Question 9.) With what Frequency do you Recommend Fecal Occult Blood Test 
Screening?  
Frequency Recommended Percentage (n) 
Not at all 2.6 (7) 
Once a year 58.3 (158) 
Every two years 28.8 (78) 
Every 3-5 years 7.4 (20) 
Not sure 3 (8) 
 
 Table 6.9 demonstrates the responses to Question 10 which posed a variety of situations 
to physicians in which they might encounter difficulties in encouraging screening for their 
average risk patients. As with prior questions, respondents could indicate how frequently they 
encountered these situations on a six-point Likert scale. All of the weighted means were in the 
three or below range signifying that the three lower-frequency response categories were chosen 
most often for each situation listed. As such, none of the issues appeared to be encountered 
frequently by most family physicians. Availability of colonoscopy was the most problematic 
issue with almost 40% of the sample reporting that this posed a difficulty in encouraging 
screening ‘often’, ‘most of the time’, or ‘always’. Patient discomfort due to colonoscopy was 
reported as a difficulty ‘often’, ‘most of the time’ or ‘always’ by 21.8% of the sample. The other 
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screening modalities addressed (DRE and FOBT) and anxiety about screening did not frequently 
pose difficulties to physicians in encouraging screening.  
 Question 10 also offered an ‘other’ category where respondents could provide input on the 
difficulties encountered in encouraging CRC screening for their average risk patients. Only five 
physicians supplied additional information in the ‘other’ category. Example of difficulties 
expressed were: “Dietary” and “I had not previously considered the patient description on page 
1 (of the survey) as 'average risk’.” 
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Table 6.9 (Question 10.) I have difficulty encouraging colorectal cancer screening for my average risk patients when: 
Procedures n Never 
1 
2* 3± 4‡ 5^ Always 
6 
4 + 5+ 6 Weighted 
Mean 
Colonoscopy is not readily available 258 21.3 18.6 20.5 19 15.1 5.4 39.5 3.04 
My patient expresses anxiety about results of the 
screening procedures and / or treatment for 
CRC 
262 15.6 32.4 39.7 9.9 1.9 0.4 12.2 2.51 
My patient expresses discomfort with 
colonoscopy 
261 12.3 19.5 46.4 18.0 3.4 0.4 21.8 2.37 
My patient expresses discomfort with DRE 256 14.5 31.6 37.9 12.9 1.6 1.6 16.1 2.60 
My patients expresses disgust with FOBT done 
at home 
256 22.7 35.5 31.3 7.8 1.6 1.2 10.6 2.34 
* Rarely  ± Sometimes  ‡Often  ^Most of the Time 
  
 The key question in this survey asked respondents whether they would support a 
population-based FOBT screening program for all eligible persons in the province over 50 years 
of age. The response to this question was overwhelmingly positive with 256 (94.8%) of family 
physicians saying that they would support such a program.  
 Physicians who responded in the affirmative to Question 11 were provided with a list of 
reasons why they might support population-based screening and were asked to select all reasons 
that applied to them. An open ‘other’ category was also included in this question. The percentage 
of physicians in support of an FOBT screening program that selected each of the reasons 
provided is shown in Table 6.10. Percentages do not sum to 100% as each respondent could 
choose more than one category.  The non-invasive nature of FOBT and that it is quick and 
simple to do were the reasons most often chosen by physicians. Cost-effectiveness of FOBT and 
the incidence of CRC seen in NL were the next most common reasons, each chosen by roughly 
three-quarters of the sample. A higher level of acceptability and mortality reduction were the 
least commonly chosen reasons. Nonetheless, over half of the sample selected each of these 
reasons.  
Table 6.10 (Question 12.) Reasons for Supporting a Population-Based FOBT Screening 
Program  
Reason Percent Selecting 
Non-invasive 91.0% 
Quick and simple to do 89.8%  
Cheaper than other screening options 78.9% 
High incidence of CRC in NL 75.0% 
Reduces CRC mortality 66.0% 
Higher level of acceptability than other 
screening options 
60.5% 
Other 9.4% 
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 Almost 10% of physicians also selected the ‘other’ category and some provided 
qualitative information to articulate these other reasons. Reasons included the role that 
programmatic screening could play in taking the onus off physicians to remember to offer 
screening to all their patients aged 50+; the easy availability of FOBT; convenience for patients 
in that they could take the test at home; and decreased risk of an adverse event when compared 
with some other screening modalities. Some of examples of other reasons for supporting a 
population-based FOBT screening program are listed below.  
“Available to everyone.” 
“Doesn't depend on office-based recall systems etc. which only addresses patients who visit their 
family doctor.” 
 
“Easiest initial screen for average risk patients”. 
 
“I'm up to my neck in my practice. To do screening properly it needs more than just an 
individual GP’s resources.” 
 
“It doesn't take up my time in an office visit that is already overburdened with the three other 
issues that patient came in with!” 
 
“It is the second most common cause of cancer and a very high cause of cancer deaths. 
Demographic shift with population aging.” 
 
“Less risk of complications, geographic reasons.” 
 
“No patient travel out of the community.” 
 
“Risks associated with colonoscopy and high dose radiation with CT colonography.” 
 
“Simple way to prevent an awful death.” 
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 Physicians who were not supportive of a population-based FOBT program (n = 14) were 
asked to respond to Question 13 which provided a list of reasons why they did not support such a 
program. An ‘other’ category was provided for this question. Table 6.11 displays the percentage 
of non-supportive physicians selecting each reason. A perceived high proportion of false 
positives and false negatives was the reason most commonly chosen, followed by patient 
unwillingness or inability to comply and lack of cost-effectiveness. The potential reasons for 
non-support provided on the survey were not as commonly endorsed as many of the reasons for 
support. However, the sample of non-supportive physicians comprised only a very small portion 
of the whole sample. 
Table 6.11 (Question 13.) Reasons for Not Supporting a Population-Based FOBT Screening 
Program  
Reason Percent Selecting (n) 
High proportion of false positives and false 
negatives 
85.7% (12) 
Patient unwillingness or inability to comply 57.1% (8) 
Not cost-effective 42.9% (6) 
Other 14.3% (2) 
 
  
Only two physicians provided other reasons for non-support. One physician stated that,  
“Bleeding is often a late sign - polyps need to be removed earlier.” Presumably the bleeding this 
physician is referring to the presence of occult blood in the stool that is detected by FOBT. The 
other comment was, “We do not have ability to follow up on in the province!” This is likely 
referring to the increased demand that an FOBT screening would place on endoscopy resources. 
This physician appears to feel that the endoscopy capacity in NL cannot cope with more 
referrals.  
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 The final survey question asked physicians to indicate their level of agreement with the 
guideline recommendation that people at average risk for CRC be screened every two years 
starting at age 50 years. Reponses ranged from ‘strongly disagree’ to ‘strongly agree’ on a six-
point Likert scale. Figure 6.6 shows the response distribution. Over 75% of respondents chose 5 
or 6 on the Likert scale and over 90% selected one of the top three response categories  (4, 5 or 
6), indicating a relatively high level of agreement for the average risk screening guideline from 
this physician population.  
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Figure 6.6 Agreement with Average Risk CRC Screening Guideline Recommendation  
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6.2.3 Summary of Screening Questions 
 All physicians reported being aware of FOBT prior to taking the survey. Most felt they 
had a responsibility to advocate for CRC screening and that they did a good job communicating 
with their patients about screening strategies. The biggest barrier to discussing CRC screening 
was having patients with co-morbidities, which was chosen ‘often’, ‘most of the time’ or ‘ 
always’ by 40% of physicians. Other barriers listed on the survey were reported to a lesser 
extent. Most physicians commenced CRC screening with their average risk population at the 
recommended age, however, only a quarter reported stopping screening at the recommended age. 
Colonoscopy was the most commonly recommended screening test for average risk patients, 
followed by FOBT completed at home. Almost all of those using FOBT in their practice knew 
the correct screening interval. The most common difficulty encountered in encouraging 
screening was the lack of availability of colonoscopy (which would impact both colonoscopy 
and FOBT screening). All but 5% of physicians said they would support a population-based 
FOBT screening program if one were available, and the most common reasons for endorsing a 
program were that FOBT was non-invasive, cost-effective and simple to do, and because of the 
high incidence of CRC in NL. Of the small proportion of the sample that said they would not be 
supportive of a population-based FOBT screening program, the most common reason for non-
support was the high proportion of false positives and false negatives obtained with FOBT 
screening. Finally, most physicians were supportive of the guideline recommendation to begin 
FOBT screening at age 50 in their average risk patients.  
 Further analyses of the physician survey are not presented due to the high level of family 
physician support expressed for a population-based FOBT screening program. Physician support 
was the primary question of interest. With only 14 (5.2%) respondents indicating they would not 
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support a screening program, analysis of supporters and non-supporters at the univariate or 
multivariate level was not found to make a meaningful contribution to understanding predictors 
of support for an FOBT screening program. Future research and analysis will provide an 
opportunity to explore whether stated support at the pre-implementation phase is reflected in 
family physician referral patterns to the screening program, once it is implemented 
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Chapter Seven 
Discussion 
7.1 Target Population Survey  
7.1.1 Primary Hypothesis 
 The primary hypothesis of this study was that those at average risk for CRC who resided 
in a region of the province with the presence of a familial cluster of high genetic risk CRC would 
be more likely to report a positive screening intention than those living in regions without such a 
presence. Counter to the study hypothesis, no significant difference in intention was found 
between areas with and without a familial cluster of high genetic risk CRC. Comparison of the 
three regions at the univariate level showed those living in the HRR area were proportionally 
more likely to feel uncertain about whether or not they would undergo FOBT screening than 
individuals in the other two regions. This was an unexpected finding, given the hypothesis. In 
light of the finding that individuals in the ARR region were significantly more likely to have 
heard of FOBT and to have used it previously, one possible explanation for increased uncertainty 
in the HRR region individuals might be that living in an area with a familial cluster of high 
genetic risk for CRC could bring about heightened awareness of people who are screened and 
surveilled using colonoscopy – which is the appropriate modality for those at increased risk. It 
may be that due to this awareness, colonoscopy is the more recognized and preferred method for 
individuals in this area, regardless of their risk level.  
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7.1.2 Secondary Hypothesis 
 Hypothesized differences in screening intention by urban versus rural area of residence 
was a secondary question of interest. Geography, in particular rurality, has been shown to be a 
predictor of poorer health outcomes and increased risk factors for chronic disease, including 
cancer106,107. As such, a lower rate of reported positive screening intention was hypothesized in 
the ARR population when compared with the ARU population. Within NL, certain disparities 
have been noted in the cancer diagnosis and treatment trajectories for rural-dwelling residents 
including longer wait times to resolution of an abnormal breast screen and lower rates of 
radiation therapy use108,109. US studies comparing urban and rural dwelling residents on CRC 
screening-related outcomes found lower screening participation rates and lower likelihood of 
being up to date with CRC screening in rural residents110-114.  In this study, however, no 
significant difference was found between urban and rural populations on intention to screen.  The 
ARR population had the highest proportion of reported positive screening intention, although 
this was not significant. It is not known what the influencers of positive intention might be in this 
group. 
 Comparing the groups on intention as either three distinct regions or collapsing the two 
average risk regions into one average risk category did not reveal any significant differences. 
Screening intention was also examined using a ten-point scale. This analysis was also run 
keeping the three distinct regions and collapsing the two average risk groups into one. Neither 
test showed a significant difference. It can be stated that, in NL, neither the presence of a familial 
cluster of high genetic risk CRC nor rurality appear to play a significant role in influencing 
intention to participate in CRC screening.  
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7.1.3 Total Sample Analyses 
The majority of those who responded to the average risk population survey reported a 
positive intention to participate in FOBT programmatic screening if a kit were sent to their home 
(70.3%). A small proportion of the sample reported a negative intention and slightly more 
reported being uncertain about participation. This was an unanticipated finding. It was expected 
that there would be a greater degree of variation across the intention response choices, as has 
been the case in other studies of screening intention. Duncan et al.(2009)84 found that only 35% 
of their respondent population (Australia) reported being prepared for screening or had already 
screened, over 65% of respondents (US) in Weinburg et al.85 (2009) reported no plans/no need to 
undergo CRC screening, and in both Sifri et al.88 (2010) and Janda et al.91 (2010), US and 
Australia, approximately half of respondents reported being ready or likely to screen. In the Sifri 
study, an additional 41% reported feeling unsure about screening participation. In no other 
studies was there the overwhelmingly positive response rate found as for the respondent sample 
in this study. It is unclear why positive intention to engage in screening is so high in this sample 
of Newfoundlanders. Perhaps the high prevalence of CRC in this province may play a role. 
For the total sample, no differences were found in intention to screen by several 
demographic variables that had been reported as significant in some other studies. These 
included gender, marital status and age group. While self-rated health status did not show a 
significant association with intention at the univariate level, the significance level observed did 
fit the criteria for retention in multivariate analysis. Awareness of FOBT as a screening test and 
prior screening were more important influencers of future screening behaviours in this 
population than any of the demographic variables studied. The inconsistency, from one study to 
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the next, of which variables act as predictors for positive screening intention lend support to the 
endeavor to examine distinct populations prior to implementing a screening program as opposed 
to assuming a ‘one size fits all’ approach. In this case, only the FOBT awareness and prior 
screening variables remained significant in multivariate model.  
7.1.4 Limitations 
 One limitation of the average risk population survey is that considerable challenges were 
encountered with sample recruitment. The method of data collection was changed early on from 
telephone survey to mail-out survey due to a very low response rate. Despite other studies on 
screening intention achieving a much higher response rate via telephone survey, this was not true 
for this population. Although mail-out yielded a better response rate, it was still relatively low at 
12.1%. Ultimately, the sample size for the HRR area was not realized. This challenge persisted 
despite attempts to reach respondents in this area via other means including, phone calls and 
emails to community groups. The full population from which to sample average risk individuals 
living in an area with a cluster of individuals at high genetic risk CRC was considerably smaller 
than the available populations for the ARR and ARU populations. Nonetheless, the response rate 
achieved for the HRR region was disappointing and somewhat surprising. Given the potentially 
higher prevalence of people with CRC in this area, it was expected that these individuals would 
be the most motivated to respond. Due to the reduced sample size of the HRR area, the power to 
be able to detect certain group differences may have been lost. Had the full sample size been 
attained, perhaps different results would have observed. However, of the responses obtained, a 
higher proportion of respondents from the HRR reported uncertain intention to screen compared 
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with respondents from the two average risk areas. Thus, the data that were obtained from HRR 
did not indicate a tendency toward the predicted hypothesis.  
Restrictions of the Personal Health Information Act (PHIA), a piece of provincial 
legislation that governs privacy, were prohibitive to taking a more targeted and population-based 
approach for recruitment of the average risk survey. Use of the province’s client registry, an up-
to-date population database, would have allowed for more rigor to be applied to the sampling 
strategy and would have opened up the possibility of reminder letters being issued to non-
responders. This may have potentially increased the sample size and allowed for a better use of 
financial resources relating to the mail-out. Restrictions under PHIA are also likely to impact the 
implementation of the screening program. Work is ongoing to attain a special designation under 
PHIA that would lift some these restrictions for the Cancer Care Program, but this designation 
has not yet been realized.  
 Required samples sizes were realized for the ARU and ARR areas, although this also 
proved to be somewhat challenging until a $10 incentive was offered to each respondent during 
the third round mail-out. Perhaps if a $10 incentive had been used from the outset, the HRR 
sample might have been attained. The extent of recruitment challenges, however, were only 
made apparent after the second mail-out. It was assumed that the low response rate when the 
survey was attempted by telephone was a methodology issue, perhaps respondent discomfort 
with speaking directly to someone about CRC screening and cancer. Similarly, the issue with the 
poor quality of address information used in the first round mail-out was thought to be the major 
influencer of low response rate on that iteration. Nevertheless, the second round mail-out, using 
the better quality Canada Post’s unaddressed admail system did not yield the response rate 
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desired. For the third mail-out it was not possible go back and do another round in the HRR 
because all households in the relevant communities had already been sent a survey package in 
the second mail-out. Surveys were returned anonymously, so there was no way of knowing who 
had already responded. Resending surveys to households in the HRR area during the third mail-
out would have introduced severe contamination into the study as it was entirely possible that 
some of the same individuals would have returned a second survey in order to avail of the $10 
incentive. As described in the Methods chapter, it was not possible to approach other areas of the 
province to increase the sample size for this distinct population. With respect to the ARR and 
ARU areas, the $10 incentive assisted in reaching the necessary sample sizes. It is not known 
whether the $10 incentive might have biased the make-up of the respondent population in some 
way. It is possible that those individuals who were motivated to screen were more likely to 
participate in a phone conversation or respond to the survey than those were not interested in 
screening for CRC. This could have introduced bias into the sample and may, in part, account for 
the very high positive screening intention reported by the total sample. If this is the case, it could 
imply that non-respondents were not as likely to have a positive intention to engage in screening. 
Given the low response rate, this may mean there is a large proportion of individuals in these 
regions who do not intend to participate in FOBT. Program implementation will reveal 
participation rates in each of the surveyed areas.  
 Finally, the relatively high level of awareness of FOBT in the overall population, when 
compared to other study’s findings92,95, likely contributed to the high rate of positive intention to 
engage in screening. The two variables were strongly associated. The high degree of positive 
intention, while encouraging, made comparative analysis between the groups on screening 
intention challenging.  
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7.1.5 Future Considerations 
 Follow-up work in this area could focus on whether the high level of positive intention is 
reflected in the rate of actual participation in the FOBT screening program. This analysis could 
be done for the overall provincial population and by subgroups, for example, by region of the 
province or by demographic factors. Empirically, intention to be screened is one the strongest 
and most consistent factors associated with future cancer screening. This has been found to be 
the case for various disease sites131,132,133,134,135,136,137,138. Follow-up work would present an ideal 
opportunity to further explore the intention - behaviour relationship on a population level. While 
prior screening behaviour cannot be modified, awareness of FOBT has also been shown to be a 
predictor of screening intention in the NL target population. If actual participation in FOBT 
screening is found to be lacking, strategies to heighten awareness of the FOBT test may prove to 
be a feasible way to enhance screening uptake, which ultimately will enhance positive patient 
outcomes.  
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7.2 Family Physician Survey  
Almost half of all family physicians in NL responded to the survey, which was 
considered an acceptable response rate. Responses by gender were reflective of the gender 
breakdown for all family physicians in the province.  All respondents reported being aware of 
FOBT as a screening modality for CRC and there were high levels of agreement that family 
physicians had a responsibility for supporting and advocating screening. There did not appear to 
be significant challenges to CRC screening encountered by family physicians as evidenced by 
the responses to questions on barriers to and difficulties associated with CRC screening. 
7.2.1 Screening Practices and Screening Support  
 With respect to screening practices, almost all physicians reported that they initiated 
screening with their average risk patient at age 50, in accordance with recommended guidelines. 
Very few reported that they did not routinely recommend screening. Interestingly, physicians 
were much less compliant with the recommended guideline for the age to discontinue screening. 
Almost half of the respondent population reported not routinely stopping screening at any age, 
and an additional 25% reported an incorrect age. This calls into question the degree of awareness 
of this recommendation and perhaps an unclear interpretation of the principles of screening; 
particularly the importance of having a defined target population that stands to garner the most 
benefit from screening. Furthermore, physicians also reported using colonoscopy most frequently 
as the screening method for their average risk population, which is not supported by the 
guidelines. 
 The primary variable of interest in the family physician survey was reported support for a 
population-based CRC screening program. Physicians were almost unanimously supportive of 
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programmatic screening using FOBT, a finding which was not anticipated, particularly given the 
reported preference to use colonoscopy. Moreover, other studies of family physician knowledge 
and attitudes toward screening showed more variability in their physician populations118, 119. 
Perhaps physicians in NL who were supportive of FOBT screening were more likely to respond 
to the survey or perhaps the way the question was asked, providing only yes / no response 
choices led to such a high proportion responding in the affirmative. However, these response 
choices were selected deliberately to avoid a majority of physicians choosing an ‘uncertain’ 
category.  
The level of reported family physician support for population-based programmatic FOBT 
screening in NL is encouraging, as is the high level of reported agreement with the guideline 
recommendation that people at average risk for CRC be screened every two years starting at age 
50. However, these findings are divergent with reported screening practices in that most 
physicians did not cease FOBT screening at 74 years of age and, as such, were not practicing in 
accordance with the recommendation. Furthermore, the majority of physicians reported using 
colonoscopy to screen their average risk patients which does not mirror their reported support 
for, and agreement with, FOBT screening and FOBT screening guidelines. It is not known why 
this disparity exists in attitude versus practice. Although gFOBT had long been available for use 
by physicians at the time of administration of this survey, utilization did not appear to be high 
and available statistics on FOBT were not of good quality. It may be that the launch of CRC 
screening on an organized, programmatic basis will bring physicians’ screening practices more 
in line with their reported support for this screening method and its guidelines for use.  
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7.2.2 Limitations 
 As with the average risk population study, such a high proportion of respondents 
choosing the same response category on the primary question of interest rendered analysis and 
interpretation challenging. It is unknown if this was due to the binary structure of the response 
categories for the support question; if the level of support for programmatic screening is 
genuinely that high; or if there were other reasons. Providing a broader range of response 
categories or using a Likert type scale might have yielded a different result.  
7.2.3 Future Considerations 
 Because this study was conducted at the pre-implementation phase of the CRC screening 
program, there is now opportunity to follow-up and examine the family physician referral rate to 
the program. Enrollment into the screening program can either happen by patient self-referral or 
physician referral. Implementation of the program is being conducted on a phased-in basis by 
Regional Health Authority, starting with Western Health, then Central Health, followed by 
Labrador-Grenfell Health and lastly, Eastern Health. This means that, in addition to examining 
physician referral patterns at the provincial level, intra-provincial comparisons can also be made.   
With the launch of the program in each region, there is a plan to educate family physicians about 
the screening program and to provide information materials for use in clinics. Follow-up research 
could focus on whether education efforts will result in physician buy-in into the program. Given 
that family physician support has been demonstrated to positively impact screening 
uptake18,19,20,21, investigation of referral patterns when the program is operational is a logical next 
step that may help to enhance screening uptake in the target population, thus ensuring maximum 
benefit of the program.  
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